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ABBREVIATIONS   USED  IN  THE  STUDY 


BAER  Brainstem  Auditory  Evoked  Response 
TG    Thyroglobulin 
DIT    Diiodotyrosine 
MIT    Monoiodotyrosine 
TSH    Thyroid  Stimulating  Hormone 
NCoR     Nuclear receptor  Co  repressor 
SMRT  Silencing  Mediator  for  Retinoic  Acid   and  Thyroid  
   Hormone  Receptor 
SCH    Sub Clinical Hypothyroidism 
EEG     Electro  Encephalogram 
IPL      Inter Peak Latency 
DCN    Dorsal  Cochlear  Nucleus 
AVCN   Antero  Ventral  Cochlear  Nucleus 
PVCN    Postero  Ventral  Cochlear  Nucleus 
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ELISA   Enzyme  Linked  Immuno  Sorbent  Assay 
BMI                        Body  Mass  Index 
BRAINSTEM  AUDITORY  EVOKED  RESPONSES  IN  NEWLY  
DIAGNOSED  HYPOTHYROID  INDIVIDUALS 
Abstract 
Background:Hypothyroidism  is one of  the  most common  endocrine 
disorder,  affecting  the  females  predominantly  than  males.  Thyroid  
hormone  deficiency  affects  almost  all  organ  system  of  our  body  including  
auditory  pathway.  Sensori  neural  hearing  loss   is  the most common 
otolaryngological  manifestations  of  thyroid  dysfunction. Evoked potentials  
are  the best  methods  which  have  been  used extensively in the study of  brain 
disturbances  and  to  a  lesser degree in metabolic diseases.  Brainstem 
Auditory Evoked Response (BAER)  is one of the method used for assessing the 
pathology in the brainstem auditory pathway.  
Aim   and  Objectives: To evaluate the auditory sensory  process in the 
brainstem by using Brainstem auditory evoked responses in the newly 
diagnosed hypothyroid individuals. 
Study  Design  :  This  is  a  Cross  sectional  study    
Participants : Forty  newly  diagnosed  hypothyroid  females  of   20 – 50 years 
were  taken  as  cases  and   forty  age    matched  females  were  considered  as  
controls.  The  hypothyroidism  was diagnosed by estimating  the  serum levels 
of  free T3(fT3), free T4 ( fT4)  and TSH.   
Methodology : After getting informed written consent, a  thorough clinical 
assessment by detailed history ,systemic and neuro - otological examination 
have been done in both cases and controls.  The  absolute  latencies  and  
interpeak  latencies of BAER were recorded  using  Neuroperfect EMG 2000 
system with installed BAER  in the research laboratory, Department of 
Physiology,  Coimbatore  Medical  College,  Coimbatore  and  the  data  were  
analyzed  by  student  unpaired t test. 
Results  :The  absolute  latencies  I, III, V  and  inter peak latencies I- III, III- 
V, I – V  were  significantly  prolonged in  newly diagnosed hypothyroid 
females (p < 0.0001)  and  also  there was direct correlation between thyroid 
profile  changes and the BAER latencies. 
Conclusion : The results  of  the  present  study  suggests  that  hypothyroidism  
affects  the  auditory pathway  in diffuse pattern  and  the  involvement of 
auditory pathway  in thyroid hormone deficiency can be identified by using  
BAER at an early stage itself.  The  prolongation of BAER  latencies  in newly 
diagnosed  hypothyroid females  was  due  to  defective  myelination of  neural 
pathways  and  diminished cerebral metabolism.  Hence it may be worthwhile to 
add  the  BAER recordings in  the  list  of  screening  tools  for  a  more  
accurate  and  early  assessment  of  neurological  involvement  in  hypothyroid  
individuals . 
Keywords : Hypothyroidism, Brainstem Auditory Evoked Responses, 
Sensorineural hearing loss. 
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INTRODUCTION 
 
Hypothyroidism  is  the  most  common   prevailing  endocrine  
disorder  among  all  endocrine  maladies.  It  is  an  altered  metabolic  
state,  when  the  body  produces  insufficient  amount  of  thyroid  
hormone.  Hypothyroidism  is  not  only  a  disorder  of  endocrine  
system,  it  also  affects  almost  all  the organ  system  of  our  body.   
The  wide  range  of  disease  severity  from  asymptomatic  state  to  
coma  makes  it  an  elusive  clinical  entity. 1  
 Hypothyroidism  is  referred  to  as  “Silent  Disease”  because  the  
early  stage  of  disease  is  asymptomatic.  About  1.6  billion  people  are  
at  risk  of  getting  thyroid  disorders  worldwide. 2  According  to  
National  Health  and  Nutrition  Examination  Survey III (NHANES)   
approximately  4- 5%  of  population  in  the  developed  world  is  
suffering  from  hypothyroidism  and  about  4 -15%  of  people  by  
subclinical  hypothyroidism. 3 
The  most  common  cause  of  hypothyroidism  is  iodine  
deficiency. In  India,  hypothyroidism  is  classified  under  the  group  of  
Iodine  Deficient  Disorders (IDD). 4  Since  1983  India  has  been  
following  the  Universal  Salt  Iodization  Programme.  As  a  result  of  
it,  there  has  been  a  decline  in  the  prevalence  of  IDD. 5  In  2004,  
WHO  assessment  of  global  iodine  status  documented  that  India  has  
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optimal  iodine  nutrition  and  now  is  undergoing  transition  from  
iodine  deficiency  to  sufficiency  phase. 6   But  a  nationwide  
comprehensive  epidemiological  study  done  in  the  eight  cities  of  
India   found  that  the  prevalence  of  hypothyroidism  was  10.95%.  
One  third  of  them  (3.47%)  are  not  even  aware  of  their  disease .  
Females  are  more  prone  to  have  hypothyroidism  than  males (15.86%  
to  5.02%).  Unnikrishnan  AG et al  has  observed  high  prevalence  of  
hypothyroidism among  the  Indian  adult  population. 4  
Thyroid  hormone   governs  the  rate  of   metabolism of  fats,  
carbohydrates,   proteins  and  also  regulates  the  timing  and  pace  of  
the  CNS  development.  It   is extremely  important  for  the  growth  of  
cerebral,  cerebellar  cortex  in  terms  of  axonal  proliferation,  branching  
of  dendrites,  synaptogenesis,  and  myelination .  Thyroid   hormone  
enhances  the  wakefulness,  response  to  various  stimuli   like   auditory  
sensation,  learning  and  memory  capacity. 7  
By  enhancing  the  gene  expression  it  influences  the  synthesis  
of  myelin.  Myelin  synthesis  is  an  important  factor  determining  the  
speed  of  impulse  transmission  along  the complex  neural  pathway  
which  mediates  the  evoked  potentials. 8  So  thyroid  hormone  
deficiency  leads   to  delayed  neuronal  conduction  along  the   central  
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nervous  system  as well as  the  peripheral  nervous  system  which  
reduces  the  perception  of  all  the  sensory  stimuli.   
About  60%  to  80%  of  the  patients  may  have   features  of  
central   nervous  system  dysfunction  like  delayed  mentation,  
depression    and  sensory deficits. 9  Among  the  sensory  dysfunctions  
hearing  loss  is  an  invisible  abnormality  which  will  lead  to   
devastating  consequences  in  interpersonal  communication,  
psychosocial  wellbeing,  quality  of  life   and  economic  independence.  
About  25  to  30%  of  the  adult  hypothyroid  patients  are  
having  hearing  loss.  In  1948    Means  et  al  stated  that  hearing  loss  
is  one  of  the  troublesome  symptom  of  hypothyroidism  and  it  may  
be  conductive,  sensorineural  or  mixed  hearing  loss. 10  Being  a  
metabolic  hormone,  thyroid  hormone  deficiency  leads  to  reduction  
in  the  cell  energy  production,  oxygenation  and    metabolism  of  all  
the  organs  including  inner  ear  structures  like  stria  vascularis  and  
the  organ  of  corti. 11   
Thyroid  hormone  deficiency   produces  delay in  the impulse  
transmission  which  leads  to   alterations  in  hearing  threshold .  All  
these  neurological  complications  of  hypothyroidism  will  resolve  
completely with  thyroid  hormone   replacement  especially  when  
diagnosed  at  the early stage.12  
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Malik  et  al  said  that  in  hypothyroid  patients  the  site  of  lesion  
in auditory  pathway  remains  speculative  and  it  may  be  at  several  
levels  like   at  middle ear,  at  cochlea  and  retro cochlear  sites. 13   
Hearing  loss  in  infants  and  children  due  to  congenital  
hypothyroidism  results  in  serious  impairment  in  language,  
communication  skills,  cognitive  and  emotional  development.  In  
adults  hearing  loss  will  lead  to  loneliness,  social  isolation,  
psychiatric  disturbances,  depression,  occupational  stress  and  
relatively  low  earnings. 14   There  are  literatures  pointing  out  that  
early  treatment of hypothyroidism  will  reverse  the  hearing  loss. 11, 15-17  
The  integrity   of  the  auditory  pathway  is  essential  for  the  
capture  of  the  acoustic  signal  by  the  external  ear  to  the  coding  of  
signals  in  the  auditory  cortex.    Impedance   audiometry,   Tonal  
threshold   audiometry   and   electrophysiological   studies   can   be   
used  to  assess  the  auditory  pathway  in  hypothyroid  patients.                        
Among  the  electrophysiological  studies evoked  potentials  provide  a  
more  reliable  and  objective  measure  of  the   integrity  of  the  related  
sensory  pathway.18  
Brainstem  Auditory  Evoked  Response  (BAER)  has    emerged  
as  an  effective  method  of  revealing  the  involvement   of  auditory  
pathway  even  in  asymptomatic  stage  itself. 9  Brainstem  Evoked  
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Auditory  Response  are  produced  in  response  to  brief  auditory  
stimulation. 19,20   In  this  technique  following  a  brief  acoustic  
stimulus,  a   series  of  potentials  are  generated  which  corresponds  to  
the  sequential  activation  of  peripheral,  pontomedullary,   pontine  and  
midbrain  portion  of  auditory  pathway.    So  BAER  helps  to  evaluate  
the  integrity  of  the  auditory  pathway.20   Persons   who  are  having  
abnormal  brainstem  response  to  auditory  stimuli  more  prone  to  
develop  Sensory  neural   Hearing  loss(SNHL). 21  
Howarth  and  Lloyd  proposed  that  perceptive  deafness  is  the  
most  common   type  of  hearing  loss  in  hypothyroidism. 10   Von’t  
Hoff  and Stuart,22  Parving  et  al 23  and  Isam Al24  also  had  found   that  
sensory  neural  hearing   loss  was  the  predominant  type  in  
hypothyroid  patients.     
Now  a days  BAER  is  mainly  used  for  screening  the  preterm  
infants  and  also  prior  to cochlear  implantation.  The  BAER  recording  
for  finding  the  functional  integrity  of  auditory  pathway  is  rarely  
performed  in  hypothyroid  patients  in  neurology  and  otolaryngology  
practice.  The  findings  of  various  studies   stated  that   the  delay  in  
the  auditory  processing  time  may  provide  the  information  about  the  
subclinical  involvement  of  central  as  well  as  peripheral  neuropathy  
in  hypothyroid  individuals.  So  BAER  can  be  used  as  a  screening  
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test  to  find  the  central  nervous  system  involvement  and  the  hearing  
loss  in  hypothyroid  patients  even  in  the  earlier  stage  itself.   
Keeping  all  these  in  mind,  in  this  study   an  endeavor  has  
been  made  to  find  the  changes  in  the  BAER  in  newly  diagnosed  
hypothyroid  individuals.   
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AIMS  AND  OBJECTIVES 
 
 To  record  the  Brainstem  Auditory  Evoked  Responses (BAER)  
in  newly  diagnosed  Hypothyroid  females  and  Controls. 
 To  compare  the  Brainstem  Auditory  Evoked  Responses  among  
newly  diagnosed  Hypothyroid  females  and  Controls. 
 To  find  the  correlation  between  thyroid  profile  and  the  BAER  
latencies  and  inter peak  latencies.   
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REVIEW OF LITERATURE 
 
Thyroid  gland  is  the  first  endocrine  gland  to  be  developed  in  
the  fetus. Among  various  hormones ,  from  the  fetal  life  up  to  the  
old age,  thyroid   hormone   is  the  key  hormone  for  the  development  
and  regulation  of  nervous  system. 7  It  is  synthesized  from  the  
largest  endocrine  gland,  the  thyroid  gland  and   large quantities  of  
hormone  are  stored  within  the  gland  itself.  It is   secreted  as  less  
active  pro hormone  and  is  then  converted  into  active  form  in  the  
peripheral  tissues. 25 Hypothyroidism  is  the  most  common  endocrine  
disorder  worldwide.  It  is  associated  with  delayed  mental  processing  
and  prolonged  latencies  of  evoked  potentials.  Brainstem  auditory  
evoked  responses  is  a  simple  noninvasive  procedure   helps  to  detect  
the  impairment  of  CNS  as  well as the  auditory  pathway.  
History  of  Thyroid  Gland:  
Galen (130 – 210 AD) was  the  first  person  described  about  the  
thyroid  gland. 26  The  name  “Thyroid”  was  given  by  Thomas  
Wharton  in  1656,  because  of  its  close  proximity  to  the  thyroid  
cartilage.  In  Greek  ‘thyreos’  means  shield.  In  1952  Gross  and  Pitt -
Rivers  discovered  triiodothyronine (T3) . 27   
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Embryology :  
 The  morphogenesis   of  the  thyroid  gland  begins  with  the  
formation  of  thyroid analgae , the  primitive  pharynx  formed   by  the  
thickening  of  the  endodermal  epithelium  of    the  foregut  at  16th 
embryonic  day.28  This  median  thickening   invaginates   behind  the  
tuberculum  impar   and  form  an  outpouching  of  the  endoderm  called   
thyroglossal   duct.  Thyroid  gland  develops  from  this  duct  and  it   
descends  caudally  infront  of  the  hyoid  bone  and  the  laryngeal  
cartilage,  assumes   bilobate  shape  then  fuses  with  the  fourth  
pharyngeal  pouch  at  7th  week  of  gestation.29  The  bilobate  mass  
divided  into  small  median  isthmus  and  two  large  lateral  lobes.   
Histological  alterations  occur  within  the  lateral   lobes   and   
then  converted  into  primary  thyroid  follicles.  Subsequent   buddings  
and  differentiation  produce  secondary  or  definitive  follicular  cells.  
By  the  3rd  month  of  gestation,  the  follicles  begin  to  be  filled  with  
colloid. 30 
Anatomy of   Thyroid Gland:   
The  human  thyroid  gland  is  butterfly  or  capital  “H”  shaped  
that  straddles  the  larynx  and  trachea  at  the  level  of  5th,  6th ,7th  
cervical  and  first  thoracic  vertebrae.  It  is  yellowish  brown  in  colour  
and  weighs  about  25g.   It  has  two   lobes  which  are  connected  by  a  
ANATOMY  AND  HISTOLOGY  OF  THYROID  GLAND 
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narrow  isthmus  which  lies  in front  of   the  trachea.31 The  lobes  are  
roughly  pyramidal  in  shape  about  5cm  long  and  3 cm  wide.  The  
isthmus  is  quadrilateral  in  shape  and  it  is  12 – 20 mm  long ,  20 mm  
wide.  It  corresponds  to  the  first  and  second  tracheal  rings. 31 
Blood  Supply : 
It  is  a  highly  vascularized  gland  and  each  minute  it  receives 
blood  flow  of  about  5  times  the  weight  of  the  gland  that  is  4 – 
6ml/g/min  of  blood. 28  This  amount  of  blood  is  derived  from  the  
superior  and  inferior  thyroid  arteries. The  venous  return  of  the  gland  
is  by  three  veins  on  each  side  namely,  the  superior,  inferior  and  
middle  thyroid  vein  which  in  turn  drain  into  internal  jugular  vein. 32 
Histology :  
The  thyroid  follicle  is  the  structural  unit  of  the  thyroid  gland.  
It  is  a  spherical   structure  of   about  200 - 300µm  in  diameter.  It  is  
lined  with  thyroid  follicular  epithelial  cells  (thyrocytes)  which  is  
either  simple  cuboidal  or  low columnar  cells.  The  epithelium  sits  on  
the  basal  lamina,  which  is  surrounded  by  fenestrated  capillary  
network  which  provide  the  route  for  the   hormones  from  the  gland  
to  the  systemic  circulation.   The  apical  side  of  the  epithelium  faces  
the  lumen  of  the  follicle. 33 
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 The  follicles  contain  pink  staining  gel  like  proteinaceous   
substance  called   colloid  which  forms  the  greatest  mass  of   the   
gland.  The  colloid  is  predominantly  composed  of  Thyroglobulin  
which  is  a  glycoprotein  secreted  and  iodinated  by  the  follicular  
cells.   Thyroglobulin(TG)  is  an  inactive  storage  form  of  thyroid  
hormone.7 
The  size  of  the  follicular  cells  and  the  colloid  amount  are  
dynamic,  vary  with  the  activity  of  the  gland.  When  the   gland  is  
inactive,  it  contains  large  follicular  cells,  abundant  colloid  and   
flattened  epithelial  cells.34  If  the  gland  is  active,  the  follicles  are  
small  and  have  tall  columnar  cells.  They  contain  scanty  colloid   
because  of  active  reabsorption  of  colloid  into  the  thyrocytes   and   
they  form   “reabsorption  lacunae”  within  the  follicles. 7  
There  are  two  types  of   cells  are  present .    
1. Follicular  cells 
2. Para   Follicular  cells 
Follicular  cells  are  the   principal  cells  responsible   for  the  synthesis  
of  T4  & T3.  Para   Follicular  or  C  cells  derived  from  the  neural  crest   
are   widely  dispersed   amidst  of   the  follicular  epithelial  cells  which  
secrete  Calcitonin. 25 
 
 RECOMMENDED  DIETARY INTAKE OF  IODINE 
 
Age   Group Daily   Requirement 
Children 90 – 120 µg/dl 
Adult 150 µg/dl 
Pregnant women 200 µg 
 
DIETARY SOURCES OF IODINE 
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Biosynthesis  of   thyroid  hormones 
The  raw  materials  for  the  synthesis  of  thyroid  hormone  are ,  
 Iodide 
 Thyroglobulin (TG) 
Iodide: 
About  50 µg/day  of  iodide  is  required  for  the  normal  
production  of  thyroxine .  Total  plasma  concentration  of   iodide  is  
0.3 µg/dl. To  meet  this  daily  dietary  intake  of  iodide  is  500µg  is  
needed. 7  
Dietary  sources : 
Richest  source  is  sea  fish 
Others :  bread,  milk,  vegetables  and   drinking  water. 35 
One  part  sodium  is  added  to  every  100000  parts  of  sodium  
chloride  in  the  common  salt  as  prophylaxis  to  prevent  iodine  
deficiency. 
Thyroglobulin (TG) : 
It  is  a  large  glycoprotein  synthesized  by  the  Rough  
endoplasmic   reticulum  and  Golgi  apparatus  with  Molecular  weight  
of  660k Da.  They  dimerized  and  combine  with  carbohydrate  moiety  
to  form  complete   molecule. 34  Each  molecule  contains  about  123  
tyrosine  amino  acid  residues.  They  combine  with  iodine  and   form  
 SYNTHESIS AND  SECRETION  OF  THYROID  HORMONE 
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thyroid  hormone.  Thus  inside  the  thyroglobulin  thyroid  hormones  
are  formed  and  secreted  into  the  colloid  by  exocytosis  which  is  
facilitated  by  thyroid  peroxidase  enzyme. 36 
Steps  in  the  synthesis  of  thyroid  hormone:28,36 
Biosynthesis   of  thyroid  hormone   is  taking  place  in  following steps: 
Iodide  trapping:  
It  is  the  first  step  in  the  formation  of  thyroid  hormones.  
Extraction  of  iodide  into  the  thyrocytes  occur  via  Sodium  Iodide  
Symporter (NIS  or  SLC5A )  in  the  basolateral  membrane.28  The  NIS  
cotransports  one  iodide  ion  along  with  two  sodium  ions  against  the  
electrochemical  gradient.   Thus  iodide  pump  concentrates  iodine  20  
to  40  times  as  that  of  the  plasma.   If  the gland  is active  it  can  
concentrate  as  high  as  250  times. 34,36 
Oxidation  of  iodide  to  iodine:  
Once  iodide  enters  into  the  thyroid  follicular  cells,  it  rapidly  
transported  into  the  lumen  by  a   sodium  independent   Chloride – 
Iodide  counter  transporter  called  Pendrin  (SLC26A4) .  Within  
seconds  iodide  is  oxidized  to  iodine  by  thyroid  peroxidase (TPO).  
Mutation  of  pendrin  gene  leads  to  Pendred  syndrome  which  is  
characterized  by  thyroid  dysfunction  and  sensorineural  deafness. 34 
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Organification  of  Thyroglobulin:   
Iodination  of  tyrosine  residues  in  the  thyroglobulin  molecule  
is  called  organification  of  thyroglobulin.   The  TG  molecules  are  
released  into  the  lumen  by   exocytosis  and   the  iodide  molecules  
enter  via  Pendrin  into  the  lumen. As  soon  as  the  oxidized  iodine  
enters  into  the  lumen,  it  binds  with  1/6th  of  the  tyrosine  residues  
within  the  TG  molecule.36 
Coupling  reaction :   
Iodinated  tyrosine  form  Mono iodo tyrosine(MIT)  and  Diiodo  
tyrosine(DIT). 36 The  main  product  of  coupling  reaction  is  thyroxin 
(T4),  which  is  formed  by  the  condensation  of  two  molecules  of  
DIT  in  which  iodine  atoms  are  found  at  3,5,3’,5’ positions.  Whereas   
T3 (triiodothyronine)  is  formed  by  the  condensation  of  one  molecule  
of  MIT  with  one  molecule  of  DIT  and  it  contains  three  iodine  
atoms  at  3,5,3’  position.36 
Storage :   
Thyroid  gland  is  the  only  endocrine  gland   that  stores  large  
amount  of  its  hormone  for  many  months.  It  is  sufficient  for  the  
new  hormone  synthesis  for  about   2 - 3 months   without  
supplementation. 36,38   
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The  proportion  of  storage  is   58%  of  iodotyrosines (23% is 
MIT  and  35%  is  DIT),  35%   of   T4,  7%  of  T3  and  only  traces   
amount  of  ReverseT3 . 28 
Release  of  thyroid  hormone:  
For  the  secretion  of  thyroid  hormones  into  the  circulation,  the  
stored   thyroglobulin  must  undergo  proteolysis.   It  happens  by  
binding  of  TG  with  the  Megalin -  a  TG  receptor  present  on  the  
apical  membrane. 7  Then  endocytosis  of  colloid  occurs  with  the  
formation  of  pinocytic  vesicle  in  the  apical  cytoplasm.  Lysosomes  
with  the  active  proteases  like  Cathepsin  D   fuses  with  this  pinocytic  
vesicles  and   releases  the  thyroid  hormones  (T3&T4)  along   with  
iodotyrosines  (MIT&DIT) .  Thyroid  gland  releases  80µg (103nmol)  of  
T4,  4 µg   (7nmol)  of  T3  and  2 µg (3.5nmol)  of  RT3  daily. 34 
Transport  of  thyroid  hormone: 
The  total  plasma   concentration  of  T4  is  8 µg/dl  and  T3  is      
0.15 µg/dl  of  which  only  0.04%  of  T4  and  0.4%  of  T3  are  in  the  
free  form. 34 The  free  form  is  the  physiologically  active  form  that  
acts  on  the  target  tissues.    
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Majority  of  the  hormones   are  in  bound  form  and  they  bind  
with  the  plasma  proteins  like, 26 
 Thyroxin  Binding  Globulin (TBG) 
 Albumin  
  Transthyretin (TTR)     
Among   the  three  proteins  TBG  has  high  affinity  for  T3  and  T4  . 
70%  of  T3 & T4  bind  with  TBG  and  form  large  circulating  reservoir  
for  thyroid  hormones. 7  
T4  is  more  avidly  bound  to  plasma  proteins  than  T3.  It  is  the  
reason  for the  long   half-life  of  T4.  Half-life  of  T3  is  7 days  and  for  
T3  is  1day. 38    
Regulation  of  thyroid  hormone  secretion:  
The  interplay  between  the  thyroid  hormones  with  Thyrotropin  
releasing  hormone (TRH)  and  Thyroid  stimulating  hormone (TSH)   
helps  to  maintain  the   secretion  of  thyroxine.  TRH   secreted  from  
the  hypothalamus   stimulates  the  anterior  pituitary  to  secrete  TSH   
which  in turn  increases  the  thyroid  hormone  secretion.  The  
circulating    free  hormones  send  feedback  signals  to  the  
hypothalamus  and  pituitary  for   regulation  of  the  TRH, TSH  release.  
Thus  the  hypothalamo  pituitary  thyroid  axis  controls  the  thyroid  
hormone  secretion. 39 
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Thyroid   Stimulating  Hormone (TSH): 
It  is  otherwise  known  as  Thyrotropin.  It  is  a  glycoprotein  
with  the  molecular  weight  of  about  28kD ,  consists  of  2  subunits  α  
and  β.  The  gene  for  the  α subunit   present  in  chromosome 6  and  
for  the  β  subunit  in  chromosome 1.  The  α  subunit  is  structurally  
similar  to  Luteinizing  Hormone,  Follicular   Stimulating   Hormone 
and  Human  chorionic  Gonadotropin.  The   β  subunit  is  unique  and  it  
has  specific  binding  properties. 34,39 
TSH   binds  to the  specific  TSH  receptor  on  the  basolateral  
aspect  of  the  thyroid  cell.  It  is  a  G  protein  coupled  receptor  and  
its  gene  is  located  in  the  chromosome  14.  It  activates  cyclic  
adenosine  monophosphate (cAMP)  and  the  phosphoinositol  pathway.   
It  leads  to  synthesis  and  secretion  of  thyroxine.  From  the  iodide  
trapping  up to  the  release  of  T4 ,T3   into  the  circulation,  all  steps  are  
stimulated  by  TSH.   It  also increases  the  cell size  and  the  
vascularity   of  the  gland. 7 
Auto regulation  of  thyroid  hormone:   
If  the  rate  of  thyroid  hormone  secretion  increases  to  1.75  
times  normal,  eventually  the  TSH  secretion  falls  to  zero  by  the  
negative  feedback  effect  of  thyroxine  on  the  anterior  pituitary  and  
the  hypothalamus.  T3  causes  repression  of  TSH β subunit  expression  
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and  decreases  the  TSH  secretion.  And  also  by  inhibiting  the  
expression  of  pre pro TRH  gene,   T3  decreases  the  TRH  secretion   
from  the  hypothalamus.  Reduced   TSH,  TRH  levels  decreases  the  
thyroid  hormone  synthesis.  Thus  thyroid  hormone  regulates  its  own  
secretion. 39 
Role  of  iodide  in  the  regulation: 
Iodide  itself  is  an  important  regulator  of  thyroid  secretion.   It  
has  biphasic  action.  At  low  levels,  thyroid  hormone  synthesis  is  
directly  proportional  to  the  iodide  intake.  If  the  iodide  intake  
exceeds  2mg/day  it  inhibits  the  thyroid  hormone  production  by  
acting  on  the  three  steps  of  hormone  biosynthesis -  the  iodide  
trapping,  thyroglobulin  iodination  and  the  release.  For  that  iodide  is  
suppressing  the  activity  of  NAPDH  oxidase,  NIS  and  the  TPO  
gene.  This  effect  is  transient  one  and  it  is  known  as  Wolf  Chaikoff  
Effect. 7  But  normal  thyroid  gland  escapes  from  this  effect  as  the  
intrathyroidal  iodide  level  falls  after  10 to 14 days.  Sometimes  in  
patients  with  multinodullar  goiter,  excess  iodide  can  induce  
hyperthyroidism.  This  is  called  as  Jod  Basedow  effect. 7  
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Mechanism  of  action  of  thyroid  hormone   
Thyroid  hormone  has  action  on  almost  all  the  tissues  of  the  body.  
Like  steroid  hormones,  it  also  has  both  genomic  and  nongenomic  
actions. 36 
Genomic  Actions: 
Thyroid  hormone  enters  the  cell  via carrier  mediated  transport.  
Inside  the  cell  T4  is  converted  by  5’ deiodinase  into  T3.  T3  binds  to  
the  nuclear  receptor  present  in  the  nucleus .  In  humans  two  thyroid  
hormone  receptors(TR)  genes  are  present.  They  are  TRα  and  TRβ  
and  their  genes  are  located  on  chromosome  17  and  chromosome  3  
respectively.  Each   gene  spliced   to  form  two  isoforms.  TR α 1 & 2  
and  TR β 1&2  of  which  TR α2  does  not  bind  with  T3.  Each  
receptors  having  ligand  binding  domain  on  the  carboxyl  terminal  
and  DNA  binding  domain  in  the  center  with  2  cysteine  zing  finger.  
They  are  attached  to  Thyroid  Response  Elements (TRE).  Regarding  
tissue  distribution,  cardiac  and  skeletal  muscle  predominantly  
contains  TRα 1,  whereas  liver  and  kidney  contains  TR β1.  TRβ2  is  
expressed  in  pituitary,  hypothalamus,  cochlea  and  retina. 7  
Thyroid  receptors  form  dimerization   with  retinoic  
receptor(RXR).   The  unliganded  TR-RXR  complex  bind  with  several  
co repressor  proteins  like  NCoR  (Nuclear receptor  Co  repressor)  and  
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SMRT (Silencing   Mediator  for  Retinoic  Acid  and  Thyroid  Hormone  
Receptor).  When  T3  binds  with  the  receptor  complex  the  
corepressors  are  released  and  co activators  are  activated  and  they  
promote  histone  acetylation  results  in  large  number  of  mRNAs  
followed  by  RNA  translation  leads  to  formation  of  new  intracellular  
proteins. 36 
Non  Genomic  Actions: 
Non  genomic  actions  of   thyroid   hormone  is  independent  of  
gene  transcription. The  actions  occur  within  minutes  in the  plasma  
membrane,  cytoplasm  and  mitochondria.  The  actions  are  effected  by  
the  interaction  of  thyroid  hormone  with  certain  enzymes  like  
adenylate  cyclase,  Ca2+ATPase  and    pyruvate  kinase.  Some  of  the  
non-genomic  actions  are  oxidative  phosphorylation,   ion  channels  
regulation,  activation  of   cAMP 2nd  messenger  system  and  protein  
kinase  signaling  cascades. 7, 36 
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Physiological  Actions  of  Thyroid  Hormone 
Calorigenic  Action:   
Thyroid  hormone  increases  the  basal  O2  consumption  in  
almost  all  tissues  of  the  body  except  adult  brain, Anterior  Pituitary, 
spleen ,  lymphnodes,  uterus  and  testes .   Increased   O2  consumption  
leads  to  excessive  heat  production.  It  is  called  as  calorigenic  or  
thermogenic  actions  of  thyroid  hormone.  This  is  exerted  by  
increasing  the  Na+ - K+ ATPase  activity37,39. 
 T3  increases   the  number,  size  and  activity  of  mitochondria  
which  in  turn  increases  the  ATP  formation. 
 Thyroid  hormones  regulate  the  oxidative  phosphorylation  
by  promoting  the  cytochrome  oxidase  activity  and  
increasing   the  expression  of   uncoupler  proteins   like   
UCP-1,UCP-2 &UCP-3.   
 The  basal  metabolic  rate (BMR)  is  increased  60  to  100%  
of  normal  by  the  thyroid  hormone.  In  completely  athyroitic  
people  the   BMR  is  reduced  to  40%   of   normal. 37 
Effects  on  Intermediary  metabolism:  
Thyroid   hormone  augments  the  expression  of  genes  encoding  
the  various  enzymes  involving  metabolic  pathways.  There  by  it  
amplify  all  the  intermediary  metabolism. 7,36,37,39 
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On  Carbohydrate  metabolism: 
Thyroid  hormone  increases  the  absorption  of  glucose from  the  
GIT  and  also  the  uptake  of  glucose  by  the  cells.  T3  enhances  the  
glycolysis  and  gluconeogenesis  as  well  as the  insulin  secretion  
parallel   to  the  increment  in  the  plasma  glucose.  So  the  net  effect  
is  no  substantial  increase  in  the  plasma  glucose  level. 26  
On  Fat  metabolism: 
By  stimulating  the  lipoprotein  lipase  enzyme  T3  accelerates  
the  lipolysis  and  increases  the  free  fatty  acid  concentration.  But  it  
lowers  the  plasma  cholesterol  concentration  without  increasing  the  
metabolism.  The  possible  mechanism  is,  thyroid  hormone  increases  
the  number  of  hepatic  Low  Density  Lipoprotein (LDL)  receptors  
which  removes  the  LDL  rapidly   and   increases   biliary  secretion  of  
cholesterol. 36  
Effect   on  Protein  Metabolism: 
Thyroid  hormone  increases  the  protein  turnover  by  promoting   
protein  degradation. 7   
Effect  on  metabolic  actions  of  other  hormones: 
It  increases  the  effects  of  glucagon,  cortisol,  epinephrine,  
norepinephrine   and  growth  hormone  on  the  ketogenesis  and   
proteolysis  of  the  tissue  proteins34.  
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Cardiovascular  Effects:   
Thyroid  hormone  increases  the  heart  rate,  myocardial  
contractility  and  thereby  increases  the  cardiac  output.  Peripheral   
conversion  of  T4  to  T3  doesn’t   takes  place  in  the  cardiac  
myocytes.  So  T3  diffuses  into  the  myocardium  and  exerts  its  action  
either  directly  or  indirectly. 
Direct  Action : 
It  increases  the  expression  of  Myosin   Heavy  Chain  α isoform,  
thereby  increases  the  myocardial  contractility (+ve  ionotropic  effect)  
directly. 
Indirect  Action:   
It  increases  the  responsiveness  of  the  myocardial  tissues  to  
the  catecholamine  by  increasing  the  β adrenergic  receptors. 
Blood  Pressure (BP): 
T3  accentuates  the  transcription  of  Ryanodine  Ca2+  channels  which  
promotes  the  Ca2+    release  from  the  sarcoplasmic  reticulum  and  
increases    myocardial  contractility  during  systole  thereby  increases  
the  systolic  BP. 36  It  also  increases  the  expression  of  Sarcoplasmic  
Reticulum  Ca2+ ATPase  pump  which  causes  sequestration   of   Ca2+   
and  facilitates  the  myocardial  diastolic  relaxation.  Because  of  +ve  
ionotropic  effect  the  systolic  BP  is  moderately  elevated.  Diastolic  
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BP  is  decreased  by  the  thermogenic  cutaneous  vasodilatation    and  
release  more  number  of  vasodilator  metabolites  into  the  blood  and  
thereby  decrease  in  the  total  peripheral  resistance. 7,37 
Heart  Rate: 
T3  increases  the  expression  of   β adrenergic receptors  gene  on  
the     SA node and   the  AV  node.  Thus  increases  the  Heart  rate. 37 
Effects  on  Respiratory  System: 
Thyroid   hormone   maintains   the  normal  arterial  PO2  & PCO2  
by  enhancing  the  ventiltory  response  to  the  hypoxia  and  
hypercapnia. 37   
Hematopoietic  Effects:   
2,3 DPG  content  is  increased  by  T3  and  shift  the  ODC 
(oxygen  dissociation  curve)  to  the  right  thereby  ensures  the  easy  
availability  of  O2  to  the  tissues.  It  induces  the  Erythropoietin  
production  by  the  kidney  resulting  in  increased   red  cell  mass.39 
Gastro  intestinal  effects:  
Thyroid  hormone  enhances  the  appetite,  food  intake  and  
reabsorption  of  glucose  from  GIT.  It  increases  the  gastric  juice  
secretion,   the  bowel  motility  and  decreases  the  transit  time. 39   
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Skeletal  Muscle  Effects:   
Skeletal  muscle  requires  adequate  amount  of  thyroid  hormone  
for  their  normal  function.  Because   it  increases  the  glycolysis  and  
glycogenolysis  and   lowers  the  glycogen  and  creatinine   phosphate  
concentration.  Creatinine   phosphate  is  essential  for  the  conversion  
of  ADP  to  ATP,  thereby  it  regulates  the  energy  production  and  
storage  in  muscle. 7 
Effects  on  Renal  System :   
Thyroid  hormone  promotes  the   growth  of  the  renal   tubular  
epithelial  cells.  It  increases  the  renal  blood  flow,  GFR  and  also  it  
enhances  the  reabsorption  of electrolytes,  glucose  and  water  by  renal  
epithelial cells.37 
Effects  on  Reproductive  Organs :   
Thyroid  hormone  has  a  permissive  role  in  the  regulation  of  
reproductive   function  in  both  sexes.  In  women  it  regulates  the  
follicular  development,  maturation  and  ovulation.  In  males  it  
promotes  spermatogenesis  and  differentiation  of  pre pubertal  cells. 7 
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Endocrine  Effects : 
Thyroid  hormone  controls  the  other  endocrine  gland’s  actions.  
It  increases the secretion of growth hormone  from  the  pituitary  
somatotropes  and decreases the  prolactin  secretion  from  the  
Lactotropes.  Paratharmone ,  1,25 dihydroxy cholecalciferol (Vit D)  
production  is  decreased  by  the  thyroid  hormone  thereby  prevents  
the  bone  resorption. 37 
Effects  on  Musculo  Skeletal  System:  
 Thyroxine   stimulates  the  enchondral  ossification  and  
epiphyseal  bone  center  maturation.  During  fetal  life  it  
enhances  the  maturation  of  chondrocytes  in  the  cartilage. 
 The  eruption  and  development  of  the  tooth  depends  on  the  
thyroid  hormone. 
 It  decreases  the  synthesis  but  increases  the  degradation  of   
glycosaminoglycan  (mucopolysaccharides)  and  fibronectin. 7   
CNS  Effects:  
Brain  development  maximally  occurs  in  the  last  6  months  of  
fetal  life  and  the  initial  6  months  of  postnatal  life.  During  this  
period  adequate  amount  of  thyroxine   is  essential  because  astrocytes  
contain  type II  deiodinase (D2) which  converts  the T4  into  T3  and   
executes  following  actions. 37 
ACTIONS  OF  THYROID  HORMONE  ON  CNS 
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 It  promotes  the  growth  of  the  cerebral,  cerebellar  cortex  and  
basal  ganglia. It  also increases  the  axonal  proliferation,  
branching  of  the  neurons,    synaptogenesis,  myelination  and  
cell  migration. 7 
 It  promotes  the  synthesis  of  enzymes  essential  for  the  
neurotransmitter  production   and  also  increases  the  number  of  
receptors  for  the neurotransmitters. 
 It  enhances  the  myelin  formation  by  inducing  the  
glactosylsialyl  transferase  activity,  thereby   increases  the  speed  
of  nerve  impulse conduction. 
 It increases  the  synthesis  of  protein  and  enzymes  like  succinic  
dehydrogenase  and  make  avail  the  ATP  for  the  nervous  tissue  
function. 
 By  stimulating  the  reticular  activating   system,  it  promotes  the  
wakefulness,  alertness,  awareness  of  hunger,  learning  and  
memory. 39 
 Adequate  thyroid  hormone  is  necessary  for  the  normal  
emotional   status  of  an  individual. 
 Thyroid  hormones  are also  important  for  the  speed  and  
amplitude  of  reflexes.  It   shortens  the  reaction  time  of  
stretch  reflexes  like  ankle  Jerk  or  achilles  reflex. 
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 It  plays  a  vital  role  in  the  development  of  cochlea.  So  its  
deficiency  leads  to  deaf  mutism. 37 
Action  on  Auditory  System: 
Thyroid  hormone  has  prominent  effects  on  nervous  systems  
through  its  role  in  gene  expression,  myelin  production,  
neurotransmitter  release,  and   axonal  transportation.  Likewise  for  the  
proper  development  of  auditory  system,   adequate  levels  of  thyroid  
hormones  are  required.40   The  exact  mechanism  of  thyroid  hormone  
role  in   the  hearing  is  uncertain,  the  possible  relationship  is  
revealed  by  recent  cellular level  and  molecular  level  experimental  
studies. 
 Morlies et al  found  that  like  other  cranial  nerves,  VIII  cranial 
nerve  also  has  peripheral  and  central part.    Thyroid  hormone  
enhances  the  genes  responsible  for  the  myelinogenesis  process  and  
both   parts  undergo  myelination  simultaneously. In  peripheral  nervous  
system        P0 ( Peripheral  Protein  Zero),  MBP (Major  Basic  Protein)  
are  the  genes  expressed  in  schwann  cells  whereas   in  CNS  along  
with  MBP,  PLP(Proteo Lipoid Protein)  are  expressed  in  
oligodendrocytes  for  myelination.  Thyroid  hormone  ensures  the  
expression  of  all  these  genes  in  cochlea,  brainstem,  inferior  
colliculus  and  auditory  cortex. 41 
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TR β2  receptor  proteins  are  present  in  the  central  intradural  
part  of  the  auditory  nerve.  T3  exerts  its  action  via  these  receptors.  
Thus  thyroid  hormone  accelerates  the  myelination  process  which  is  
the  prerequisite  for  the  spreading  of  action  potentials  from  the  
periphery  to  brainstem.    The  development  of  cochlea  also  requires  
adequate  levels  of  thyroxine  during  fetal  life. 41   
In  the  mechanism  of  hearing,  the  hair  cells  are  the  main   
structure  involved  in  the  transduction  of  sound  waves  into  neuronal  
impulses.   Thomas  weber  et  al  suggest  that  thyroid  hormone  acts  as   
the  first  transcriptional  regulator  of   the  motor  protein – Prestin  in  
the  outer  hair   cells.  It  is  related  to  sulfate / anion transport  process.  
It  is  important  for  enhancing  the  amplitude  and  clarity  of  the  
sound. 42 
 Brandt  et  al   did   a   study  using  the  patch  clamp  technique  
found   that   fast   acting   K+ channels   and    calcium   channels   in   the  
inner  hair  cells   (IHC)   require   thyroid   hormone   for   their   
activation  and   also   observed   the   role   of   Otoferlin    for   the   
exocytosis   of    IHC.    The   developmental   studies   done   on   
hypothyroid   rats   point  out  that,  thyroid  hormone  is  also  necessary  
for  the  morphogenesis   of  cochlea  and  its  structures. 43 
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Hypothyroidism 
Hypothyroidism  is  a  group  of  clinical  symptoms  due  to  deficient  
thyroid  secretion.  It  usually  has  an  insidious  onset  and   gradually  
progresses  from  asymptomatic  subclinical  hypothyroidism  to  severe  
form  of  myxedema  coma. 
Historical  Review:   
In  1874  English  physician  Sir  Williams Withey  Gull  described  
the  full  blown  expression  of  adult  hypothyroidism .   W M Ord  
named  the  condition   as  myxedema,  because  of  the  presence  of  
mucin (myx- ) in  the  skin  and  the  subcutaneous  tissue  which  leads  
to  the  swollen (edema) appearance. 26   
In  1882  Reverdin  described  that  surgical  removal  of  thyroid  
gland  also  produces  similar  clinical  picture,  and  called  as  cachexia  
strumipriva. 44  
After  Gulls  description,  enormous  interest  was  aroused  in  
myxedema.  So  London’s  clinical  society   formed  a  committee  to  
study  and  report   its  results.  Its  report  was  published  in  1888  and  
most  of  our  knowledge   regarding  the  etiology,  clinical  and  
pathological  features  of  myxedema  are  based  on  that  report  only. 45 
In  1891  George Redmayne  Murray  was  the  person  who  first  
found  that  administration  of  the  thyroid  extract  of  sheep  to  the  
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myxedema  patients  provides  good  clinical  response.   But  the  active  
principle  of  thyroid  hormone  was  first  isolated  in  crystalline  form  
by  Edward  Calvin  Kendall  in  1941.  The  chemical  structure  of  
thyroid  hormone  was  clearly  explained  by  Sir  Charles  Harrington  in  
1926.   As  the  sheep  thyroid  extract  is  poorly  absorbed,  the  
levothyroxine  sodium  sulfate  was  identified  and  utilized  for  the  
treatment. 26 
Epidemiology : 
Several  epidemiological  surveys  depicted  that  hypothyroidism  
is  one  of  the  most  common  endocrine  disorders.  According  to  the  
update  for  primary  care  physicians  data,  about  1%  to  2%  of  all  
adults  once  in  their  lives  experiencing  hypothyroidism. 46 
Every  year  2.6  to  4.3%  of  Subclinical  Hypothyroidism (SCH)  
cases  progresses  to  clinical  hypothyroidism.  Middle  aged  Females  
are  much  more  frequently  affected  by  hypothyroidism. 45 
Regarding  the  prevalence  of  hypothyroidism  the  data  have  
been  obtained  from  the  20  year  follow up  study  of   Whickham  
survey, 47 
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Prevalence Women (per 1000) Men (per 1000) 
SCH 75 28 
Hypothyroidism  18 1 
Incidence Women (per 1000/year) Men (per 1000/year) 
Hypothyroidism 4.1 0.6 
 
Grades  of  Hypothyroidism: 
The  transition  from  the  euthyroid  to  hypothyroid  state  is  the  
initial  step  in  the  development  of  hypothyroidism.  It  occurs  by  
decreased  secretion  of  T4  from  the  thyroid  gland  which  causes  
feedback  increased  release  of  TSH  from  the  anterior  pituitary    and  
maintains  the  T4  levels  within  the  reference  range  initially.  Further  
decline  in  T4  results  in  higher  TSH  values  but  T3  levels  are  
maintained  by  the  conversion  of  T4 to T3.   
When  the  T4  level  falls  to  very  low  value,  the  T3  levels  also  
fall. Thus  the  hypothyroidism  gradually  progressed  from  SCH ,  mild  
hypothyroidism  to  overt  hypothyroidism. 48 
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Grades  Thyroid  state TSH f T4 f T3 
I SCH Slightly 
elevated 
Normal Normal 
II Mild 
hypothyroidism 
Moderately 
high 
Low  Normal 
III Overt  
hypothyroidism 
Very high Very low Low  
 
The   maintenance   of  serum  T3  concentration  till  the  great  fall  
in  T4  level serves  to  maintain  the  homeostasis  of  the  metabolism. 
Causes  of  hypothyroidism: 
Hypothyroidism  is  caused  by  variety  of  functional  and  
structural  disorders  of  thyroid  gland.  Its   severity  depends  on  the  
duration  of  hormone   deprivation.  Based  on  etiology,  it  is  broadly  
classified  into, 39 
1.Primary   hypothyroidism: 
It  is  the   inherent  inability  of  the  thyroid  gland  to  secrete  
sufficient  amount  of  its  own  hormones.  It  is  otherwise  called  as  
thyroprivic  hypothyroidism. 
2.Secondary  hypothyroidism: 
This  is  due  to  defective  secretion  of  TSH  from  the  Pituitary  
or  TRH  release  from  the  hypothalamus.  Other  names  for  secondary 
hypothyroidism   are  trophoprivic  or  central  hypothyroidism. 
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3.Thyroid  hormone  resistance  syndrome. 
I. Primary (thyroidal)  hypothyroidism: 28 
Congenital : 
 Thyroid  agenesis 
 Mutation  in  genes  encoding  NIS   and  Pendrin 
 Iodotyrosine  halogenase  deficiency 
 Organification  disorder (Thyroid  Peroxidase  deficiency) 
 TSH  receptor  defects 
Acquired : 
 Hashimoto’s  thyroiditis  
 Endemic  goiter (iodine  deficiency) 
 Iatrogenic 
 Drug  induced – Lithium,  sulfonamide,  iodide,  Sunitinib, INFα 
 Transient  hypothyroidism: 
o Postpartum  thyroiditis  and  Sub acute  thyroiditis. 
II.Central / Secondary  ( Hypothalamic  Pituitary ) hypothyroidism: 
28 
 Tumors  of  pituitary ,  craniopharyngioma, meningioma   
 Trauma – head injury 
 Surgery   
 I131 radiation 
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 Vascular – hemorrhage 
 Infections – tuberculosis, abscess, syphilis, toxoplasmosis 
 Functional  defects  in  TSH  biosynthesis – mutation  of   genes  
encoding  TRH  receptor, TSHβ  subunit,  pituitary  transcription  
factors. 
 Thyroid  hormone  resistance  syndrome – mutations  in  genes  
encoding  TRα  TRβ, MCT8 
 Consumptive  hypothyroidism – massive  infantile  hemangioma. 
 Infiltrative – Sarcoidosis,  Histiocytosis, Hemochromatosis. 
Pathogenesis  of  hypothyroidism: 
Thyroid  hormone  deficiency  affects  almost  all  organ  systems  
of  the  body.  The  characteristic  pathologic  finding  is  mucinous  non  
pitting  edema  in  the  dermis.  The  mucinous  material  is  the  
hydrophilic  hyaluronic acid   and   glycosaminoglycan  which  attracts  
more  water.  Their  excessive  deposition  is  because  of  loss  of  
thyroxine  action  on  the  degradation  of  mucopolysaccharides   and  
fibronectin. 49  In  the  musculoskeletal  system  also  the  muscle  cells  
are  edematous.  
In  cardiovascular  system  the  cardiac  chambers  are  dilated  or  
hypertrophied.  The  serous  cavities  contain  abnormal  amounts  of  
fluid.   The  adrenals  may  be  normal  or  it  may  show  cortical  
  
 
CLINICAL  FEATURES OF HYPOTHYROIDISM 
 
 
 
36 
 
atrophy.    Renal  biopsy  shows  thickening  of   basement  membrane  
and  extra  cellular  deposition  of  amorphous  material.   
The  brain  shows  gliosis,  atrophy  of  neuronal  cells.  With  
longstanding  myxedema,  mucinous  material  is  deposited  in  the  
neurons  and  form  neural  myxedematous  bodies.  It  also  produces  
neuronal  hypoplasia  and  demyelination. 50   
Systemic  Manifestations 
Hypothyroidism  Effects  on  Energy  Metabolism: 
Hypothyroidism  reduces  the  basal  metabolism  of  the  body  
which  in  turn leads  to  decrease  in  the  resting  energy  expenditure,  
oxygen  utilization.  It  leads  to  low  BMR,   reduced  thermogenesis  
and  produces  cold  intolerance  in  hypothyroid  patients.  Because  of  
fall  in  energy  expenditure  there  will  be  net  gain  in   body  weight.   
Increased   adipose  tissue  elevates  the  leptin  level,  which  
increases  the  energy  disposal  and  leads  to  reduction  in  adipose  
tissue.  In  hypothyroid  patients  plasma  leptin  level  may  be  increased,  
or  decreased  or   doesn’t  change.   
A  gastric  peptide,  Ghrelin  also  has  a  role  in  appetite  
stimulation  and  is  elevated  in  hypothyroid  patients.   Serum  visfatin  
and  serum  obestatin  are  increased  in  hypothyroidism  whereas  serum  
adiponectin  and  resistin  concentrations  doesn’t  change. 51 
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Protein  Metabolism: 
Effect  on  protein   metabolism  is  a  complex  one.  Though   
hypothyroid  state  affects  both  the  degradation  and  synthesis  of  
proteins,   a   positive  nitrogen  balance  only  exists   because  the  
synthesis  is  affected  more  than  the  degradation. 26 
Carbohydrate  Metabolism: 
Impaired  translocation  of  GLUT 4 transporters  on  the   plasma  
membrane  leads  to  decreased  glucose  uptake  by  the  skeletal  
muscles  and  by  the adipose  tissue .  Hypothyroidism  reduces  the  rate  
of  degradation  of  insulin,  so  the  insulin  requirement  is  reduced  in  
diabetic  patients  with  hypothyroidism. 28 
Lipid  Metabolism: 
Thyroid  hormone  deficiency  reduces  both  the  biosynthesis  and  
lipolysis.  The  serum  total  cholesterol  level  is  raised  due  to  down  
regulation  of  the    hepatic  LDL – receptor  which  in turn  increases  
the  cholesterol  secretion  and  biliary  secretion  of  cholesterol.                      
The  LDL  cholesterol  is  also  elevated  by  non  LDL  receptor  
pathways.Friedrich  and  Pilger  reported  that   no  change  in   neuro – 
otological  symptoms  like  dizziness,  tinnitus  and  sensori neural  
hearing  loss  in  hypercholesterolemia  patients. 52 
  
SYMPTOMS  OF  HYPOTHYROIDISM 
Constitutional  /  general Fatigue, Weight gain, Cold 
intolerance, Hoarseness, 
Periorbital edema 
Cardiovascular  Bradicardia, Diastolic 
Hypertension, Peripheral edema, 
Hyperlipidemia, Pericardial 
effusions 
Pulmonary  Dyspnea, Pleural effusion 
Gastro intestinal Constipation  
Genito urinary Decreased GFR, Elevated  
creatinine, Infertility, 
Menorrhagia 
Dermatological  Dry coarse skin, Diffuse alopecia, 
Yellow Skin 
Neurological  Poor memory, Difficulty 
concentrating, Muscle weakness, 
Nerve entrapment syndrome, 
Delayed  relaxation of deep tendon 
reflexes, Paresthesia, Impaired  
hearing , Psychosis. 
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Cardio  Vascular  System: 
 Hypothyroidism  decreases the  heart  rate  and  stroke  volume  
thereby  decreases  the  cardiac  output.  It  also  causes  
cardiomegaly  and  pericardial  effusion.   
 ECG  shows  low  voltage  P  wave  and   QRS  complex,  
flattened  or  inverted  T  wave ,  prolonged  PR  interval  and   
sinus bradycardia.26,28 
Respiratory  System: 
 Prolonged  duration  of  hypothyroidism  causes  weakness  of   
respiratory  muscles which  leads  to  alveolar  hypoventilation  and  
CO2  retention. 
 7%  of  patients  show  obstructive  sleep  apnea  syndrome.  
Obstructive  sleep  apnea  due  to  macroglossia,  narrowing  of  
pharynx   due  to  soft  tissue  infiltration  of  
mucopolysaccharides.37  
Musculo Skeletal  system: 28 
 Myalgia,  muscle  weakness,  stiffness,  cramps. 
 Pseudo myotonic  reflex  or  hung  up  reflex( delayed  relaxation  
of  deep  tendon  reflex) 
 Carpal  tunnel  syndrome. 
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Digestive  System: 36 
 Decreases  the  rate  of  peristalsis  which  leads  to  constipation.  
It   causes  fecal  impaction  in  the  colon  and  produces  
myxedema  mega  colon. As  it  decreases  the  contraction  of  gall  
bladder  it  may  lead  to  Gall stone  formation. 
Haematopoietic  System:  
 Plasma  volume,  red  blood  cell  mass  and  blood  volume  are  
decreased  in  hypothyroidism. Most  of  the  patients  suffer  from  
mild  normochromic  normocytic  anemia. Diminished  
reabsorption  of  vitamin B12  leads  to  Pernicious  anemia.  
Megaloblastic  anemia  caused  by  reduced  intestinal  absorption  
of  folic  acid. 
 Total  and  differential  count  of  WBC  is  normal. 
 Platelet  count  is  normal  but  intrinsic  coagulation  pathway  is  
defective  due  to  decreased  concentration  of  coagulation  factors   
like  factor  VIII  and  IX.   
 Coagulation  tests  showed  that  low  factor  VIII  activity,  low      
von  Willebrand  Factor,  low  or  normal  fibrinogen . 28 
Renal  System: 
 Decreased   cardiac  output   leads  to  reduced  renal  blood  flow,  
GFR  and  renal  plasma  flow.  
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 Serum  uric acid  level  increases  in  postmenopausal  women. 
 Reduced  renal  ability  to  dilute  urine  which  leads  to increased  
serum  creatinine  and  hyponatremia. 28 
Endocrine  system: 
Pituitary  and  Adreno  cortical  system: 25,27 
 Chronic  untreated  primary  hypothyroidism  results  in  thyrotroph  
hyperplasia  and  sellar  enlargement. Increases  the  serum  
Prolactin  concentration  which  may  be  associated  with  
galactorrhea. 
 The  secretion  of  growth  hormone  decreased  resulting  in  low   
serum  IGF -1  concentrations.   
 Hashimoto’s  thyroiditis  may  cause  growth  hormone  deficiency. 
The  response  of  insulin  induced  hypoglycemia  to  the  plasma  
cortisol  level  also  decreases. 
Reproductive  System: 28 
In  adult  men:  Libido  decreased. Reduced  Sex  hormone  
Binding  Globulin (SHBG)  leads  to  reduced  serum  total  testosterone  
level  but   free  testosterone  is  normal. Serum  LH  and  FSH  are  
normal,  but   their  response  to  GnRH  is   diminished.  
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In  adult  women:  Reduced  SHBG  leads  to  reduced   serum  
estradiol  and  estrone  concentration   but   free hormonal  levels  are  
normal. Hypothyroidism  also  causes  irregular   menstrual  bleeding,  
reduced  fertility,  spontaneous  abortion  and  preterm  delivery     
Nervous  System: 28 
Though  thyroxine  is  necessary  for  the  development  of  CNS  
its  deficiency  leads  to  the  following  neurological  symptoms  not  
only  in  children  but  also  in  adult  hypothyroid  patients. 
 Cognitive  and  behavioral  deficits 
 Head  ache,  poor  memory ,  depression 
 Slowdown   of  speech  and  movements 
 Deafness -  neural  or  conductive  type 
 Vertigo,  tinnitus 
 Thick  slurred  speech  and  hoarseness  of  voice 
 Delayed  relaxation  of  the  deep   tendon  reflex  leads  to  hung  
up   reflexes 
 Low  amplitude  waves  in   EEG 
 The  absolute  latencies  and  inter peak  latencies  of  evoked  
potentials were  prolonged. 28 
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HYPOTHYROIDISM  AND  HEARING  LOSS 
Sensory   system  involvement  is  more  common   among  the  
hypothyroid  patients. The  threshold  for  special  senses  like  smell,  
taste,  visual  and  auditory  impulses  also  altered.   Among   this  
hearing  loss  is  one  of  the  characteristic  and  most  troublesome  
symptom.  All  types  of  hearing  losses  like  sensorineuronal,  
conductive  and  mixed  type  of  hearing  losses  have  been  reported.  
Vestibular  abnormalities  may  be  present.  Adult  type  of  acquired  
hypothyroidism  must  be  differentiated  from  the  sensorineural  hearing  
loss  of  Pendred  syndrome.  Because   thyroid  hormone   treatment  
provides  complete   cure  to  the  acquired   hypothyroidism,  not  to  the  
Pendred  syndrome. 
 In  1907 – Kemp  was  the  first  person  who  demonstrated  the  
Sensory  Neural  Hearing Loss  (SNHL)  in  Hypothyroidism  and  
found  that  it  can  be  reversed  by  administering  the  thyroid  
extracts. 16 
 Audiometrical  documentation  of  Hearing Loss  in  acquired  
hypothyroidism  was  first  done  by  Hilger. 16 
Incidence  of  deafness  in  hypothyroidism: 
The  exact  incidence  of  deafness  in  hypothyroid   patients  
varies  from  study  to  study. 
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Vikas  Malik  from   India  by  a  study  based  on  pure  tone  
audiometry,  reported  that  11.5%  to  95%  of  cases  have  hearing  loss  
in  hypothyroid  individuals. 13  A  study  on  hearing  profile  in  
hypothyroidism  found  that  46.9% conductive  hearing  loss,  28.1%   of  
SNHL  and  25%  cases  of  mixed  type  of  hearing  loss. 
Chandrasekar M  et  al  reported  that  86%  of  mild  bilateral  
hearing  loss,  48.8%  mild  hearing  loss  and  40.62%  moderate  hearing  
loss among  hypothyroid  patients  who  are  not  on  treatment. 17 
Causes  of  Hearing  Loss: 
Even though  so  many  studies  have  been  done  to  see  the  
association  of  symptom  complex  and  the  hypothyroidism,  still  the  
association  is  poorly  understood.  The  possible  mechanisms  are,  
Conductive  Hearing  Loss(CHL): 
According  to  Meyerhoff   et al  glycogen  deposition  causes   
structural  damage  to  the  tympanic  membrane  and  partial  obliteration  
of  oval  or  round  window  which   may  be  the  reasons  for  CHL  in  
hypothyroidism.40  Hypertrophy  of  the  mucosal  lining  of   the 
Eustachian tube  and  middle  ear   can   also be a possible  mechanism. 13 
Sensorineural  Hearing  Loss (SNHL): 
 Adequate  levels  of  thyroid  hormone  is  necessary  for  the  
development    and  maturation  of  auditory  system.  So  far  it  was  
known  that  Progesterone  was  the  only  hormone  having  influence  on  
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nerve  conduction.  Now  it  was  identified  that  thyroid  hormone  also  
plays  a  main  role  in  the  myelinogenesis  process. 53  Myelinogenesis  
process  involved  the  expression  of  myelin  genes  and  the  sequential  
myelination  of  nervous  system. 
 Thyroid  hormone  ensures  the  glial  gene  expression  in  the  
auditory  system.  TRβ  is  very  much  important  for  the  myelination  
of  auditory  nerve.  In  humans  the  auditory  system  attain  full  
maturity  at  birth.  Adequate  levels  of  thyroid  hormone  is  vital  for  
the  synchronized  nerve  impulse  transmission  at  the  onset  of  hearing.  
It  was  identified  that  even  after  the  onset  of  audition   the  
myelination  of   auditory  pathway  takes  place.  So  not  only  the  
congenital  hypothyroidism,  adult  onset  hypothyroidism  also  affects  
the  myelination  and  leads  to  delayed  conduction  along  the  
brainstem  auditory  pathway. 54 
Abott  et  al  proposed  that  diminished  myelination  and  cerebral  
hypo metabolism  may  be  the  reason  for   SNHL. 55  According  to  
Cuddon  et  al,  axonal  degeneration  may  be  the  cause  for  SNHL. 17  
Knipper  et  al  found  that  thyroid  hormone  is  essential  for  the  
myelination of auditory  pathway  and  maturation  of  auditory  system. 43 
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Parving  et  al  in 198323  and   Isam  et al  n  200124  were  found  that  
SNHL  was  the  predominant  type  of   hearing  loss  in  the  
hypothyroid  people.   
Hypothyroidism -  Diagnosed  by, 
Thyroid  profile   
 Serum TSH,   
 Serum free T3   
 Serum free T4. 
Tests  for  Hearing  Loss , 
 Rinne’s  test 
 Weber’s test 
 Absolute Bone Conduction Test 
 Pure  tone  audiometry 
 Tympanometry 
Electro physiological  studies: 
 Electrocochleogram 
 Brainstem  auditory  evoked  response (BAER) 
 Transient  acoustic  emission 
Among  the  electro  physiological  studies  BAER  is  an  useful  
noninvasive,  objective  type  of  study  helps  to   assess   the  integrity  
of  the  brainstem  auditory   pathway . 56   
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EVOKED  POTENTIAL 
The  advancement  in  the   computer  signal  processing,  the  
electrophysiological  studies  gain  their  place  in  the  medical  
diagnostic  field.  It  has  become  a  useful,  objective  clinical  method  
in  assessing  the  central  nervous  system,  peripheral  nerves  and  
muscles.  Evoked  potential  is,  the  electrical  manifestations  of   brain’s  
responsiveness  to  the  external  stimulus.  Averaging  techniques  have  
been  utilized  for  recording  the  neuroelectric  responses  for  the  
diagnosis  of  neurological  disorders  like  neuropathies  and  intracranial  
tumors. The  clinical  utility  of  Evoked  Potentials  is  based  on  their  
ability, 57 
 To  demonstrate  the  abnormal  nerve  conduction  in sensory  
system. 
 To  explore  the  subclinical  involvement  of  the  nervous  system. 
 To  define  anatomic  locations  of  the  disease  processes  like  
demyelination. 
 To  monitor  the  neurological  status  of  the  person. 
In  theoretical  aspect  any  sensory  modality  can  be  tested,  but  in  our  
routine  clinical  practice,  following  tests  are  being  done  frequently, 57   
 Pattern  reversal  Visually  Evoked  Potential (PR VEP) 
 Short  latency  Somato Sensory  Evoked  Potential (SSEP) 
 Brainstem  Auditory  Evoked  Potential (BAEP) 
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Historical  Review: 56     
Since  the  early  1950s  evoked  potentials  have  been  utilized  in  the  
patients  with  neurological  disorders,  but  it  was  only  in  1970s  they  
gain  a  definite  clinical  utility.  The  history  of  development  of  the  
evoked  potentials  is  closely  related  to  the  discovery  of  electricity. 
 In  1752  - Benjamin  Franklin  discovered  the  presence  of  two  
opposing  forces  of  electricity  that  is  positive  and  negative. 
 In  1791 – The  fact  that  the  nerves  are  good  conductors  of  
electricity  was  discovered  by  Luigi Galvani. 
 In  1850 - Helmholtz   measured  the   conduction  velocity   of   
nerve  in frog. 
 In  1929 – Hans  Berger  recorded  the  spontaneous  electrical  
activity  from  the  scalp.  It  was  the  first  human  
electroencephalogram (EEG). 
 In  1939 – Davis  was  the  first  person  who  noticed  the  
electrical  potentials  on  the  human  skull  in  response  to  
repeated  auditory  stimulation. That  potentials  are  initially  
called  as “ V”  potentials  or  vertex  potentials.  These  potentials  
are  very  small  and  difficult  to  measure. 
 In  1951 – Dawson  described  the  averaging  techniques  for   the  
detection  of  small  evoked  potentials .  
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 In  1967 – Sohmer  and  Feinmesser    showed  the  placement  of  
surface  electrodes  on  the  ear  lobe  and  the  vertex.  They  were  
the  persons  who  recorded  the  BAEP  initially. 
 In  1971 – Jewett and his associate Williston described  the  human  
BAEP  wave forms  and  named  the  peaks  with  roman  numerals  
I to VII.  The  wave  forms  are  called  as Jewett  bumps.58   
 In  1975 – Starr  and  Achor  proposed  the  BAER  changes  in  
neurological  disorders. 
 In  1994 – Moller  identified  that  Inferior  Colliculus  is  the  
waveform  generator  of  the  wave  V. 
Types  of  Auditory  Evoked  Potential (AEP): 
Auditory  Evoked  Potentials  generated  in  the  brain  can  be  
classified  according  to  the  latency , 59   
 Short Latency Auditory  Evoked  Potential  with  latencies <10ms. 
 Long  latency  Auditory  Evoked  Potential  with  latencies  >50ms 
 Middle Latency Auditory Evoked Potential with intermediate 
latencies. 
Middle  and  Long  latency  Auditory  Evoked  Potentials  are  generated  
within  the  cerebral  cortex.  So  they  are  used  for  the  assessment  of  
cognitive functions.  Short  latency  Auditory  Evoked  Potential  
generated  in  the  brainstem  is  called  as  BAER. 59 
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Brainstem  Auditory  Evoked  Response (BAER) : 
BAER  is  short  latency  auditory  evoked  potentials,  which  occurs  
within  10  to 15 milliseconds  of  an  acoustic  stimulation.  Otherwise  
known  as  Auditory  Brainstem  Response (ABR)  or  Brainstem  
Auditory  Evoked  Potentials(BAEP).    It  helps  to  find  the  functional  
integrity  of  the  central  auditory  pathway  which  includes  VIII  cranial  
nerve,  Pons,  and  Midbrain. It  can  be  used  for59,60 , 
 Screening of Hearing loss and Hearing threshold estimation in 
difficult to test population like infants, children and psychiatric 
patients. 
 Differentiate  between  peripheral  and  central  nervous  system  
abnormalities. 
 Confirmation  and  localization  of  brainstem  dysfunction. 
 Intra  operative  monitoring. 
Anatomical  and  Physiological  Basis  of  BAER: 7,25,34,36 
The  human  ear  is  not  only  an  organ  of  hearing,  but  also  an  
organ  of  equilibrium.  The  auditory  system  consists  of   two  major  
portions:  the  peripheral  auditory  system  and  the  central  auditory  
system  which  function  together  to  transmit,   transduce,  propagate  
and  analyze  the  auditory  stimuli. 
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Peripheral  Auditory  System: 
Human  ear  is  made  up  of  three  parts: the  external  ear,  middle  
ear  and  inner  ear. The  external  ear  consists  of  pinna  and  external  
auditory  canal.  The   pinna  directs  the  sound  waves  into   auditory  
canal  thereby  it  is  helpful  for  the  sound  localization25.  The  external  
auditory  canal  ends  at  the  thin  transparent  membrane  called  
tympanic  membrane  or  eardrum.  The  canal’s main  function   is  to  
transmit  the  sound  pressure  waves  to   eardrum  which  has  a  
resonant  frequency  of  about  3500Hz. 7   
The  middle  ear  opens  through  the  Eustachian  tube  into  the  
nasopharynx.  It  contains  a  chain  of  ossicles   that  connect  the  
tympanic  membrane  to  the  oval  window  and  transmits  sound  waves  
to  inner  ear. 36  The  inner  ear  consists  of  the  cochlea (auditory  
component)  and  the  semicircular  canal (vestibular  component).  The  
cochlea  is  a  snail  shaped  coiled  tube  which  makes  2 ¾  turns  
around  a  central  bony  structure  called  modiolus.  The  cochlea  is  
divided  into  three  compartments  by  two  membranes – the  Reissner’s 
Membrane  and  the  Basilar  Membrane. 7   
  
ORGAN  OF  CORTI 
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The three compartments are, scala vestibuli, scala media or 
cochlearduct and scala tympani. The scala vestibuli and tympani contains 
perilymph whereas the cochlear duct is filled with endolymph. The organ 
of corti rests with its hair cells on the basilar membrane which forms the 
floor of scala media.7 The chief sensory receptor for hearing are 2 types of 
hair cells. They are,   
i. Single  row  of  inner  hair  cells (IHC)  
ii. Three  rows  of  outer  hair  cells (OHC)   
The cilia of outer hair cells project into thin gelatinous tectorial 
membrane. The inner hair cells generate action potential in the auditory 
nerve, thus it acts as a primary sensory receptor for hearing. The outer hair 
cells have different function, it responds to the sounds, depolarization 
causes shortening and  hyperpolarization  causes  lengthening  of  outer  
hair cells. It  helps to amplify the amplitude  and  clarity  of  sounds.  This  
changes attributed to prestin  a membrane protein in the outer hair cells. 34 
The  basilar  membrane  is  shorter (100µm)  near  the  base  and  
wider (500µm)  at  the  apex  of  the  cochlea.  High  frequency  tones  
produce   maximum  movements  near  the  base  whereas  low  frequency  
tones  near  the  apex.  Thus   basilar  membrane  acts  as  frequency  
analyzer. It was proposed by Von Bekesy. The  hair  cells  are  innervated  
by dendrites of bipolar cells  and  their  axons  form  the  cochlear  nerve. 7  
AUDITORY  PATHWAY 
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Central  Auditory  Pathway: 34,36 
Axons  of  the  bipolar  cells  in  the  spiral  ganglion  forms  the  
cochlear  division  of  the  VIII  cranial  nerve.  These  axons  synapse  in  
the  cochlear  nucleus.  The  Cochlear  nucleus  is  divided  into  two  
subnuclei, 
 Dorsal  Cochlear  Nucleus (DCN) 
 Ventral  or Accessory  Cochlear  Nucleus (VCN) 
The  VCN  is  further  subdivided  into, 
 Antero  Ventral  Cochlear  Nucleus (AVCN) 
 Postero  Ventral  Cochlear  Nucleus (PVCN) 62 
Tonotopic  organization  is  found  in  cochlear  Nucleus:  
Axons  of  the  lower  frequencies  from  the  spiral  ganglion  cells  
project  to  the  DCN  and  the  AVCN.  The  higher  frequency  organ  of  
corti  hair  cells  project  to  the  AVCN  and  DCN.  The  axons  from  
the  mid  frequency  end  up  between  two  extremes.   Thus  the  
frequency  spectrum  is  preserved. 7 
The  output  from  the  AVCN   passes  through  the  ventral  
acoustic  stria  which  forms  the  trapezoid  body  and  it  terminates  in   
superior  olivary  nuclei(SON)  and  inferior  colliculus. The  projections  
from  the  PVCN  mostly  go  via  the  ventral  and  middle  acoustic  stria  
to  terminate  in    superior  olivary  nuclei   and    inferior  colliculus.   
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The  DCN  forms  the  dorsal  acoustic  stria  which  terminates  in  
superior  olivary  nuclei  and  the  contra lateral  inferior  colliculus. 62 
Superior  Olivary  Complex: 
Superior  Olivary  Complex  has  medial  and  lateral  components.  
The  medial  component  receives  excitatory  input  from  both  sides  
AVCN. The  lateral  component  receives   inhibitory  inputs  from  the  
contralateral  AVCN  and  PVCN  and  excitatory  inputs  from  AVCN  
and  PVCN  via  trapezoid  body.  Thus  the  differences  in  the  activity  
of  neuron  provide  the  information  about  the  source  of  the  sound.  
Binaural  interactions  are  occur  at  the  level  of  superior  olivary  
nucleus which  is  important  for  the  directional  localization  of  sound. 7 
Lateral  Lemnisci :  From  the  superior  olivary  complex  the  fibers  
project  to   ipsilateral  and  contralateral  lemnisci.  Each  lateral  
lemnisci  ascends  along  the  dorsolateral  brainstem  upto  the  midbrain. 
Inferior  colliculus : In  the  midbrain  most  of  the  fibers  terminate  in  
the  inferior  colliculus. 
Medial  geniculate  body: From  there   the  fibers  end  in  the  Medial  
geniculate  body  of  the  thalamus. 34,36 
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Auditory  cortex: 
From  the  thalamus  auditory  radiations  project  to  the  superior  
gyrus  (Heschl’s  gyrus)  of  the  temporal  lobe  which  is  the  auditory  
cortex (area 41  &  42).  Some  fibers  project  to  the  association  cortex  
in  the  tempero  parietal  region (areas 20, 21,22). 
Cortical  Organization: 
Like  those  of  other  primary  sensory  areas,  the  primary  auditory  
cortex  has  sensory  maps  in  addition  it  has  tonotopic  maps.  Neurons  
present  in  the  primary  auditory  cortex  form  the  isofrequency  
columns  as well as    alternating  columns  of  summation  and  
suppression  columns.   
 Isofrequency  columns  -  have  the  same  frequency 
 Summation  columns  - more  responsive   to  binaural  input. 
 Suppression columns - more  responsive   to  monaural  input. 7 
Frequency  threshold: 
The  audible  range  of  human  ear  is  20Hz  to  20,000Hz.  The  
human  ear  is  most  sensitive  to  1000   to  4000Hz  range.  The  pitch  
of  the  average  male  voice  is  120Hz  and  the  female  voice  is  
250Hz. 34 
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Mechanism  of  Hearing 
The  sound  travels  through  the   air  and  it  reaches  the  external  
ear.  It  transmits   sound  waves  along  the  auditory  canal  to  the  
tympanic membrane and vibrates it. In  turn vibrations conducted  along 
the  ossicular chain up to the oval window of cochlea.  The  middle  ear  
matches  the impedance of energy from external ear to inner ear, because 
the  external  ear transmits through air and the  cochlea  through  the  
fluid.  Some  amount  of  energy  will  be  lost  as  a  result  of  resistance.  
But  this  system  raises  the  sound  pressure  that  reaches  the  oval  
window  by   lever  action  of  the  ossicles (1.3 times) .34  It  raises  the  
efficiency  of  sound  energy  transfer  by  30dB  in  the  range  of  
hearing  from  300 to 3500Hz. 7 
From  oval window  the  sound  vibrations are  transmitted  through  
the  scala  vestibuli  and   tympani  which  contains  perilymph.  Then 
these vibrations are  passing  through  the  Reissner’s Membrane  into  
scala media to the  basilar  membrane.  This  sets  up  travelling  wave  
along  the  basilar  membrane  which  stimulates  hair  cells  in  the  organ  
of  corti. The bending of stereo cilia of hair cells towards the tallest 
cilium and causes depolarization of hair cells.  This leads to the release of 
neurotransmitter especially Glutamate, which initiates the other neighbor 
afferent neuron depolarization and generate receptor potentials. 34 
56 
 
Once  the  action  potentials  are  generated  in  the  hair cells,  the  
impulses  are  transmitted  through  the  auditory  nerves  to  the  cochlear  
nucleus  which  is  the  termination  of  all  fibers  of  the  auditory  nerve.  
From  the  cochlear  nucleus  the  second  order  neurons  project  to  the  
superior  olivary  complex  via  the  trapezoid  body.  The  tonotopic  
organization  is  maintained  in  the  cochlea  and  the  superior  olivary  
Nucleus.  From  there  third  order  neurons  transmits  the  impulses  
through  the  lateral  lemniscus,  medial  geniculate  body  up to  the  
auditory  cortex  via  auditory  radiations. 36 
Brainstem  Auditory  Evoked  Response: 
The   BAER,  a  series  of  short  latency,  subcortical,   far field  
electrical  potentials  which  provide  noninvasive  measure  of  the  
potentials  from  the  VIII nerve,  pontomedulary,  pontine  and  midbrain  
portion  of  the  auditory  pathway.  These  are  volume  conducted  
evoked  potentials  which  can  be  recorded  by  using  electrodes  
placing  on  scalp.  There  are  five,  sometimes  seven  distinct  
waveforms  are  recorded  within  10 to 15  milliseconds  of  the  auditory  
stimulus,  labeled  I to VII  in  roman  figures. 56 
 WAVEFORM  GENERATORS 
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Wave  form  Generators56,60,63,64 
Wave  I: 
It  is  originated  from  the  peripheral  portion  of  the  cochlear  
nerve.  It  is  recorded  from  the  stimulated  ear  and  virtually  absent  
from  the  contralateral  ear.  It  is  necessary  to  calculate  the  central  
auditory  brainstem  conduction  time. 60  
Wave  II: 
It  has  two  separate  components,   generated  either  from  the  
intracranial  portion  of  the  cochlear  nerve  or  the  cochlear  nucleus.  It  
is  attributed  to  the  change  in  the  volume  conductor  between  the  
inside  and  outside  of  the  internal  auditory  meatus.  It  is  not  
commonly  used  in  clinical  interpretation  of  BAEPs. 63   
Wave III: 
By  the  intra operative  recordings  it  is  found  that  wave III 
produced  from  the  Pons.  Muller  and  his  associates  found  that,  
superior  olivary  complex  in  the  caudal  pons  is  the  primary  
generator  of  the  wave  III  and  some  contribution  from  the  trapezoid  
body.  It  is  present  with equidistant  between  waves I  and V.  It   may  
have  bifid  pattern  which  makes  it  difficult  to  identify. 64   
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Wave IV: 
It  has  same  peak  with  wave V  and   it  is  generated  by  the  
nuclei  of  Lateral  lemniscus  in  the  upper  pons.  Muller  and  his  
associates  found that wave IV requires intact ventral nucleus of the 
lateral  lemniscus62. 
Wave V: 
It  reflects  the  activity  of  multiple  anatomical  structures  of   
auditory  pathway.  Wave  V   is  originated  from  the  vicinity  of   
inferior  colliculus.  More  than  99%  of  the  axons  of  the  lower  
auditory  brainstem  region,  are  going  through  the  lateral  lemniscus  
to  the  inferior  colliculus.  By  the  transverse  section  experiment  it  is  
found  that  intact  inferior  colliculs  is  required  for  the  wave V. 56 
Wave  I, wave III  and  wave V  are  constant  reproducible ,  robust  
components  of  BAEP  complex,   which  are  clinically  very  much  
useful. 56,65 
Wave VI  and  VIII  : 
They  can  be  seen  in  some  individual  traces.  They  are  present  
in  70%  of  normal  BAEP  but  poorly  reproducible.  Their  origin  is  
unclear  and  less  helpful  clinically.  It  has  been  suggested  that  the  
wave VI and VII  originated  from  the  medial  geniculate  body   and  
auditory  radiation.56 
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BAER  Recording  Technique 
The  guidelines  for  clinical  and  intraoperative  recordings  of  
BAER  was  proposed  by  American  clinical  neurophysiology  society,  
2006a  and   American  Electroencephalographic  society  1994  
respectively. 59   The  BAER  amplitudes  are  in  the  sub microvolt  
range.  It  is  much  weaker  than  the  surrounding  environmental  noise,  
background  electro cerebral  activity  and  muscle  activity.  Hence  
BAER  recordings  require  special  amplifiers  called  bio amplifier  to  
make  these  signals  large  enough  for  further  signal  processing,  filters  
for  filtering  the  undesirable  electrical  activity,  digital  converter  for  
converting  the  scalp  recorded  electrical  activity  to  binary   format  
that  can  be  utilized  by  a  digital  computer  and  a  signal  averager. 65 
 
 
60 
 
Stimulus : 
A  mixed  frequency  of  broad  band  clicks (100 to 8000Hz),  
using  the  acoustic  energy  over  a  wide  range  of  audio  frequencies  
can  be  used  for  the  neurologic  evaluation.  Clicks  are  single  
monophasic  square  wave  pulse  delivering  for  100µsec  duration  by  
using  a  standard  audiometric  ear  speaker.  These  clicks  stimulates  a  
large  number  of  neurons  which  fired  simultaneously  and  produce  a  
larger  response. 59,66 
Stimulus  polarity : 
 Based  on  the  type  of  pressure  applied  to  the  tympanic  
membrane  three  types  of  stimulus  polarities  are  present.  They  are, 
 Rarefaction  click 
 Condensation  click 
 Alternating  polarity 
The clicks in which first and  most  prominent  acoustic wave creates a  
positive pressure  and  displays  the  tympanic  membrane  outwardly  is  
referred to  as rarefaction clicks . The clicks in which the  acoustic  wave  
creates  a  negative  pressure  and  displays  the  tympanic  membrane  
inwardly  is  called  as  condensation  clicks.  Alternating  polarity  is  
the  clicks  which  creates  alternating  negative  and  positive  pressure 
and displaces the tympanic membrane  inwardly  and  outwardly. 60 
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For  optimal  recording  and  resolution  of  wave I  rarefaction  click  
polarity  is  the  best  and  it  is  used  widely in  clinical  recordings. 59 
Stimulus  Intensity: 59,60,66 
The  stimulus  intensity  must  be  loud  enough  to  elicit  a  clear  
BAER  waveform  without  causing  ear  discomfort.  60 – 65 dB  above  
the  sensation  level  of  the  subject  is  optimum intensity.  Reduced  
stimulus  intensity  is  used  for  assessing  the  wave V  latency.  High  
stimulus  intensity  is  used  for  neurologic  diagnosis.  Shift  of  the  
stimulus  intensity  to  higher  level  without  change  in  its  shape  
suggests  Conductive  Hearing  Loss  while  change  in  the  shape  of  the  
curve  with  increased  slope  suggests  Sensorineural  Hearing  Loss. 59   
Stimulus  Rate:  
Stimulus  rates  are  widely  vary  from  5  to 200 / sec.   Stimulus  
rate  of   8 – 10/sec   is   optimum  for  clean  resolution  of  short  latency  
BAER.  For  individual  peak  identification  stimuli  rate  of  10 – 15 / 
sec are  used,  whereas  for  threshold  testing  higher  rates  are  used  for  
measurement  of  wave V latency.  Higher  rates  of  stimulation  reduce  
the  amplitude  of  BAER. 59,66 
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Monaural  Vs  Binaural  Stimulation: 
Acoustic  stimuli  should  be  delivered  monaurally, i.e., one  ear  
is  stimulated  at  a  time  and  responses  are  recorded  from  the  same  
ear.  It  prevent  the  influence  of  abnormal  or  absent  response  to  the  
stimulation  of  the  other  ear. 67 
Contralateral   Masking: 
To  eliminate  the  acoustic  crosstalk  that  is  bone  conducted  
responses,  the  contralateral  unstimulated  ear  is  masked  by  white  
noise  at  60dB SPL( sound  pressure level)  is  used.  Systematic  
masking  of  the  unstimulated  ear  is  recommended  for  useful  
precaution  in  routine  BAER  recording. 59,60 
Recording  Procedures: 
Subject  should  be  investigated  in  a quiet  room,  supine  or  
recumbent  position  for  the  optimum  relaxation  of  neck  and  face  
muscles.  An  electrically  shielded  room  is  never  needed  and    sound  
proofed  room  is  not  always  necessary.  It  can  be   recorded  during  
either  wakefulness  or  sleep.  Sedation  can  be  used  in  very  young  or  
tense  patients.  Because  BAER  unaffected  by  sleep,  anesthesia  and  
even  doses  of  barbiturates  sufficient  to  induce  coma. 68 
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Electrode  placement  and  Montages: 
BAER  recorded  between  the  vertex  and  both  earlobes  or  
mastoid  process.  The  surface  electrode  in  the  form  of  disc  is  most  
commonly  used  in  clinical  practice.  It  is  made  up  of  silver,  gold,  
platinum  and  stainless  steel.  Silver  or  gold  electrodes  have  stable  
electrode  polarization  potentials  which  results  in  noise  free  
recording.  After  careful  skin  preparation,  the  electrodes  are  pasted  
by  using  standard  electrode  paste  according  to  the  international  10 – 
20 system  of  EEG  electrode  placement. 59 
The  positions  are,  
 The  scalp  electrode  placed  at  the  vertex (Cz) 
 The  recording  electrodes  placed  at  the  both  ear  lobes  
(Ipsilateral Ai  &  contralateral Ac)  or  mastoid  process(Ipsilateral 
Mi  &  Contralateral Mc) 
 The  ground  electrode  can  be  placed  anywhere  in  the  body,  
for  convenience  mostly  in  the  forehead (Fz). 
Electrode  impedance  should  be  kept  less  than  5 kOhms. 56 
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Montage : 
Generally  two  channel  montage  system  is  suitable  for  most  clinical  
situations. 
Channel  1 -  Ipsilateral  ear lobe Ai  or  mastoid  Mi  - Vertex Cz 
Channel  2 -  Contralateral  ear lobe Ac  or  mastoid  Mc  - Vertex Cz 
As  BAER  are  far  field  potentials,  little  displacement  of  the  
recording  electrodes  do  not  significantly  alter  the  BAER  waves.  
Exception  is  wave I -  which  is  the  near  field  potential,  is  generated  
from  the  peripheral  portion  of  auditory  nerve. 63 
Amplification: 
The  raw  analog   data  must  be  amplified  by  high  input  
impedance  differential  bioamplifier  with  the  rejection  ratio  of  at  
least  80 dB (10,000:1).  Thus  it  amplifies  about  50,000  or  100,000 
times. 59 
Filter : 
It  allows  a  particular  range  of  frequency  from  a  signal.  It  is  
required  for  eliminating  the  noise   and  bringing  out  the  
characteristics  of  the  waveforms.   
 The  low  frequency  filters – it  is  otherwise  known   as  high  
pass filter. Because it remove the slowly changing components  up 
to 100Hz  and  allows  the  higher  frequencies  to  pass  through. 
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 The  high  frequency  filters -  it  is   also  called  as  low  pass  
filters.  It  removes  the  rapidly  changing  higher  frequency  
components  and  allows  only  the  low  frequencies.  
The  recommended  band  pass  filter  is  about  30 to 3000Hz.  In  
clinical  application,  low  frequency  cut  off  is  < 300Hz ,  high  
frequency  cut  off  is  >3kHz. 68 
Signal  Averaging : 
It  extracts  very  small  signals  which  are  buried  in  large  noise. 
Back  ground   noise  is  reduced  through  averaging  and  filtering.  
Generally  1000  to  4000 stimuli  is  used  in  averaging  to  form  a  clear  
resolution  of  BAER.   By  averaging  the  time  locked  signals,  the  
small  signals      become  prominent   and  stored.   Randomly  occurring   
noise  is   cancelled  out. 66 
Sensitivity  and  Sweep  Speed: 
The  duration  and  latency  of  evoked  potentials  is  influenced  
by  sensitivity  and  sweep  speed.  If  the  sweep  speed  increases,  it  
results  in  shortening  of  latency. Two  or  more  response  can  be  
obtained  and  superimposed  to  demonstrate  the  replicable  nature  of  
their  components.  The  sweep  rates  are  increased  or  decreased  based  
on  signal  to  noise  ratio.   
NORMAL BAER 
 
 
 
 
 
 
 
 
NORMAL  VALUES  OF  BAER  LATENCIES 
BAER Mean(ms) SD (ms) 
Absolute  Latencies 
Latency  I 1.5 0.17 
Latency  III 3.8 0.15 
Latency  V 5.6 0.20 
Inter peakLatency 
IPL  I – III 1.6 0.20 
IPL  III – V 1.7 0.20 
IPL I - V 3.9 0.20 
Right  - Left difference I- V 0.17 0.10 
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The  averaged  results  displayed  on  an  oscilloscope  to  monitor  
artifacts.  The  amplitude  of  the  stored  data  can  be  amplified  by  
increasing  the  sensitivity. 63 
Analysis  of  Results:  
 The  Amplitude  ( measured   from  peak  to  trough) 
 Latency  (the  time between  the stimulus  and  the  particular  
peak) 
 Inter  Peak  Latency ( the  time  between  peaks) 
 Inter  aural  latency ( difference  in wave  latency  between  both  
ears) 
 Wave V/I  amplitude  ratio. 
The  patient  values  are  compared  with  the  control  population  who  
are  neurologically  and  audiologically  normal,  in  whom  the  BAER  
recorded  using  the  same  stimulation  rate. 59,63 
Wave  Inter Peak  Latencies (IPL): 56,60,63 
I – III IPL: 
It  is  a  measure  of  conduction  from  VIII  nerve  across  the  
subarachnoid  space  into  lower  pons.  It  is  affected  by  tumor,  
inflammation,  or  diseases  affecting  the  proximal  portion  of  the  
auditory  nerve.  Its   upper  limit   is  2.5ms  with  the  right  to  left  side  
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difference  is  less  than  0.5ms.  The  prolongation  of   I – III IPL is  
usually  associated  with  I – V IPL   prolongation.  
III – V IPL: 
It  is  a  measure  of  conduction  time  from  lower  pons  to  
midbrain.  It  is  influenced  by  the  impulses  arising  from  the  
contralateral  side.  III -V IPL  prolongation  is  considered  abnormal  
only  when  it  is  associated  with  I - V IPL  prolongation  or abnormal  
V/I  ratio. 
I – V IPL: 
It  is  a  measure  of  nerve  impulse   conduction  time  from  
auditory   nerve  through   pons  and  midbrain.  Its  upper  limit  is  4.5ms  
with  inter aural  difference  is  less  than  0.5ms.  It  is  prolonged  in 
disorders  like  demyelination,  degeneration,  ischemia  and  tumors. 
V/I  Amplitude  Ratio: 
The  absolute  amplitudes  don’t  have  clinical  utility  as  they  are  
highly  variable  between  individuals.  To  overcome  this,  the  
amplitude  ratio  V/I is  used.  As  the  wave I  originated  from  
peripheral  portion  of  the  auditory  nerve  and  the  wave  V  from  the  
central  portion  of  the  CNS,  their  ratio  helps  to  assess  the  
synchrony    of  different  parts  of  the  auditory  pathway.  Its  normal  
range  is  between  50% to  300%.    
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Non  pathological  factors  affecting  BAER: 60 
There  are  variety  of  factors  which  should  be  taken  into  
account  while  performing  and  interpreting  BAER.  These  factors  are  
broadly  classified  into  two  categories, 
 Subject  factors 
 Technical  factors  
Subject  factors: 
1.Maturation  and  Age: 
Age  is  one  of  the  most  important  factor  while  interpreting  BAER  
waveforms.  The  first  detectable  component  in  preterm  infant  is  
wave I,  which  is  seen  in  30 weeks  of  gestation.  Wave V  is  recorded  
in  33weeks  of  gestation.  In  normal  term  neonates  the  wave V  is  
smaller  than  wave I.  Amplitude  ratio   V/I  is  reversed  compared  to  
adults.60  According  to  Stockard  et al.  the  infants  are  having  higher  
amplitude  waves  than  in  adults,  presumably  due  to  smaller  head  
size  and  greater  proximity  of  the  recording  electrodes to  BAER  
generators. 69 
2.Gender  Differences: 
The  absolute  latencies  and  IPL  are  significantly  shorter  in  
females  than  in  males  by  0.1 to 0.2ms. 70  Absolute  amplitude  is  
greater  in  females.  These  differences  are  due  to  head size,  greater  
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average brain size in  males  and  higher  core  body  temperature,  shorter  
length of brainstem auditory pathway, faster  maturation  in  females. 60, 63 
3.Body  temperature: 
For  every  one  degree  decrease  in  body  temperature    the  
latency  of  wave V  increases  about  0.15ms  to  0.2msec. 60, 63  In  
hypothyroidism,  the fall in the body temperature causes delay  in  nerve  
impulse  conduction. 
4.Subject  Relaxation:  
One  of  the  most  common   difficulties  in  BAEP  recording  is  
myogenic  response  caused  by  excessive  neck  and   facial  muscle  
activity.  This  myogenic  response  is  greater  in  post auricular  muscle  
activity  at  the  stimulated  side  and  it  can  be  reduced  by  placing  the  
subject  in  supine  position  reduces  the  neck  muscle  tone  thereby  
ensures  muscle  relaxation.  If  necessary , light  sedation  to  induce  
sleep  can  be  used,  because  anesthesia,  sleep  are  not  going  to  affect  
the  BAER  waveforms. 63 
5.Sleep:  
No  significant  changes  are  detected  in  BAER  parameters  
during  natural  sleep.  But  continuous  monitoring  reveals  that  minor  
fluctuation  may  be  present  in  waves I & V  which  are  related  to  
nocturnal  variations  in  body  temperature  not  due  to  sleep  stages.  
These  fluctuations  do  not  exceed  2%,  so  negligible. 63 
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Technical  Factors : 
1.Stimulus  intensity : 
The  resolution  of  waveforms  are  good  and  they  are  easily  
identifiable  with  the   click  intensities  above  60dB HL(hearing level).  
Changes  in  the  click  intensities  produce  changes  in  the  morphology  
of  BAEP.  When  the  click  intensities  decreases,  the  absolute  
latencies  increases  whereas  the  amplitude  decreases. 63, 66 
2.Stimulus  Polarity: 
Rarefaction  click  polarity  produce  a  larger  wave I  with  a  
shorter  latency  and  also  it  causes  better  separation  of  wave IV & V 
peaks  than  condensation  clicks.  To  reduce  the  stimulus  artifact,  
alternating  polarity  can  be  used.  So  alternating  polarity  is  used  in  
intra operative  recording  of  BAER. 63 
3.Stimulus  Frequency  Spectrum: 
In  clinical  neurophysiology  laboratories  unfiltered  clicks  with  
a  broad  frequency  spectrum  from  500 to 4000 Hz  are  used.  For  each  
specific  stimulus  frequency,  specific  regions  of  the  basilar  
membrane  in  the  cochlea  is  stimulated.  At  click  intensities  of  60 – 
70dB HL,  the  2000 to 4000Hz  regions  of  cochlea  is  stimulated. 60, 63 
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4.Stimulus  Rate: 
When  the  stimulus  rate  increases,  it  increases  the  absolute  
latency, IPL  and   decreases  the  amplitude  of  BAER  waves.  When  
the  stimulation  rate  increased  from  10 to  80 clicks / sec  all  BAER  
parameters  increased. 60   
5.Filters : 
The  frequency  spectrum  used  in  BAER  recording  falls  
between  15 and  2000Hz  and  50%  of  it  falls  in  range  below 200Hz.  
Therefore  in  clinical  neurologic  testing  high  pass  filter  is  set  at  10 
to 30Hz  and  low  pass  filter  is  set  at  2500 to 3000Hz.  This  gives  
better  resolution  of  BAER  waveforms. 60, 63 
BAER  wave  Abnormalities: 
1. Absent  wave I - tumor  in  peripheral  portion  of  VIII  cranial  
nerve. 
2. Absence  of  waves  from  II, III: 
 acoustic  neuroma 
 demyelinating  disorder 
BAER  in  Neurological  Diseases: 
 BAER  waveforms  are  used  to  document  the  brainstem  
involvement   in   non-focal  neurological  diseases,  especially  
those  affecting  the  myelin. 
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 Prolongation  of  IPL I-III &  I-V  waves  are  reflecting  the  
involvement  of   myelin  which  wraps  the  proximal  and  
immediate  intra axial  portion  of  the  cochlear  nerve. 
 BAER  also  helps  to  show  the  electrophysiological  
abnormalities  even  in  clinically  asymptomatic  individuals. 
 By  latency  intensity  study,  hearing  threshold  can  be  estimated  
and  can  be  distinguished  between  conductive  and  SNHL. 
 BAER  waveforms  are  useful  for  the  assessment  of  hearing  in    
children  and  in  patients  who  are  unable  to  cooperate  with  
conventional  audiometry.  
BAER  in  Hypothyroid  Individuals 
A  study  done  at  the  Middlesex  Hospital  London  on  1956,  
found  that  perceptive  type  of  hearing  loss  is  the  most  common  type  
than  conductive  deafness  in  hypothyroidism.  The  investigators  
Howarth  and  Lloyd  stressed  that  the  perceptive  deafness  should  not  
be  overlooked  because  unlike  other  causes  of  sensorineural  hearing  
loss,  it  shows  considerable  reversibility  with  treatment. 10   
Audiological  study  done  by   Bhatia  et  al  in  1977  found  that  
though  conductive  hearing  loss  seen  in  hypothyroidism  patients  
sensorineural  hearing  loss  is  the  most  predominant  type. 24  
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Meyerhoff  et  al (1979) in  their  study  to  find  the   
morphological, electrophysiological  and  biochemical  reasons  for  
hypothyroidism  induced  hearing  loss,  found  that  the  cochlea  is  the  
site  of   lesion. 40 
Vant Hoff  and  Stuart  in  their  study  on  deafness  in  myxedema  
observed  that  among  48  myxedema  patients,  85%  of  them  had  
sensorineural  hearing  loss. 22 
Parving  et  al 1983  in  their  study  to  find  the  hearing  
sensitivity  in  15  myxedema  patients, they  demonstrated  that  all  the  
hypothyroid  patients  had  bilateral  symmetrical  SNHL. 23 
An  evoked  potential  study  done  to  assess  the  functional  
integrity  of  the  brainstem  auditory  pathway  in  hypothyroid  patients,  
Anjana  et  al  found  that  there  is  slight  increase  in  wave  III  latency  
but  didn’t   find  any  significant  difference  in  absolute  and  inter peak  
latencies  in  hypothyroid  individuals.  But  they  found  significant  
improvement  in    latency  of  wave  III  and  IPL I - III  after  thyroid  
hormone  replacement  therapy.   By  this  study  they  proposed  that  
there  may  be  increased  conduction  time  at  the  distal  portion  of  the  
auditory  pathway  and  the  conduction  velocity  revert  to  normal  with  
hormonal  replacement. 16 
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By  recording  BAER  in  20  patients  with  hypothyroidism ,    
Anand et al  found  the  casual  relationship  between  thyroid  hormone  
deficiency  and  hearing  loss  and  demonstrated  the  prolongation  of  
absolute  latency  of  wave  I  and  IPL  of  I -III  and  I - V  among  80% 
of  their  patients.  They  concluded  that  thyroid  hormone  deficiency  
causes  retrocochlear  lesions  of  the  auditory  pathway. 72   
Thornton  and  Jarvis,  in   their  audiometric  study  on  
hypothyroid  and  hyperthyroid  patients,  found  that  in  BAER ,  
abnormal  increase  in  the  interpeak  interval  I-V  and  reduction  in  
amplitude  of  waves  III  and V   was  found  in  hypothyroid  patients  
whereas  hyperthyroid  patients  didn’t  show  any  changes  in  the  
BAER  waves  compared  to  healthy  controls.  They  reasoned  that  the  
abnormalities  are  due  to   low  body  temperature  of  the  hypothyroid  
individuals. 73   
In  a  follow  up  study  done,  Hohmann   et  al  found  that  
hypothyroidism  causes   prolongation  of  BAER  latencies  I – V .  After  
the  treatment  with  thyroxine  hormone  for  six  months  the  
hypothyroid  patients  showed  improvement   in  the  latencies. 74  
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Mahin et al found  that  prolongation  of  BAER  in  congenital  
hypothyroid  patients75.  Chou  et  al  and  Bellman  et al  by  using  
BAER  identified  the  persistence  of  neuro  otological    dysfunction  
even  after  starting  of  treatment  of  congenital  hypothyroidism. 76 
Khechinaschvili et al  in  their  study  on  the  hearing  system  
under  thyroid  hypo function  investigated  50  hypothyroid  patients.  By  
using  BAER  they  detected   30%  of  the  SNHL  cases.  In  their  study  
they  observed  that  treatment  with  thyroxine   hardly  improves  the  
hearing  disorders. 77 
Di  Lorenzo  et al  recorded  the  BAER  with  masking  wide  band  
in  56  adult   hypo  and  hyperthyroid  patients,  found  that  there  is  a  
relationship    between  BAER  alterations  and  the  degree   of  thyroid  
dysfunction. 78 
Huang  and  coworkers  in  National  Taiwan  university   who  
have  done  a  evoked  potential  study  in  thyroid  disease   patients  
reported  that  significant  prolongation  of  waveform  latencies  and  
interpeak  latency  of  BAER  seen  in  hypothyroid  patients  than  the  
hyperthyroid  patients.  Thus  they  concluded  that  central  nervous  
system   is  more  sensitive  to  hypothyroidism  than  hyperthyroidism. 79 
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Himelfarb  et  al  in  their  study  on  Auditory  brainstem  
responses  in  patients   with  thyroid  dysfunction   inferred  that  the  
characteristic  changes  in  the  BAER  were  prolonged  brainstem  
conduction  time,  flattened  peaks  and  diminished  amplitude.  He  
added  that  these  changes   correlated  well with  serum  levels  of  T4. 80  
On  the  experimental  level,  Lai  et  al  demonstrated  an  early  
increased  BAER  IPL   I -V  and  III - V  in  the  experimentally  induced  
hypothyroid  rats  and  concluded  that  CNS  is  highly  vulnerable  to  
thyroid  hormone  deficiency. 81 
Moore  et  al  observed  that,  the  acoustic  motor  reflex  and  
BAER  require  synchronized  neural  pathway  activation.  For  that  
there  will  be  tight  regulation  of  myelination  must  be  needed.  
Thyroid  hormone  regulates  the  neuronal  myelination  process. 54 
Rubenstein  et  al82  in  guinea  pigs  and  Ben  Tovim  et  al83  in  
rats,  both  of  them  induced   hypothyroidism  experimentally   in  those  
animals  and  recorded  BAER.  From  their  study  they  demonstrated  
the  prolongation  of  all  the  absolute  latencies  and  interpeak  latencies  
and  also  found  that  the  prolongation  of  BAER  latencies  directly  
associated  with  fall  in  the  serum  levels  of  free  thyroid  hormones. 
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From  all  these  evidences  it  is  clear  that  hypothyroidism  
affects  the  central  auditory  pathway,  evoked  potentials   like  Brain  
stem  Auditory  Evoked  Response  is  helpful   to  identify  the   auditory  
system  involvement .  So  in  the  current  study  we  sought  to  study  
the  absolute  latencies  and  inter peak  latencies  of  brainstem  auditory  
evoked  responses  in  newly  diagnosed  hypothyroid  individuals. 
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MATERIALS  AND  METHODOLOGY 
STUDY  DESIGN: 
This  is  a  Cross Sectional   study. 
STUDY  PLACE: 
This  study  was  performed  in  the   Research  laboratory  of    
Department  of  Physiology,  Coimbatore  Medical  College, Coimbatore. 
STUDY  PERIOD: 
The  study  period  extended  from  August 2013  to  June 2014.  
The  ethical  committee   of  the  Coimbatore  Medical  College   
approval  was  obtained  prior  to  the  commencement  of  the  study. 
INCLUSION  CRITERIA: 
A   total  of  80  subjects  of  20  -  50  years  were  included  in  the  
study.  All   participants  were  females.  Among  them  forty  were  
newly  diagnosed  hypothyroidism  patients  and  forty  were  normal  
healthy  females. 
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EXCLUSION  CRITERIA: 
 Known  patients  of  hypothyroidism  already  on  treatment,   
 Persons  working  in  noisy  environment  
 Pregnant  females,  
 Known  cases  of  any  hearing  loss,  
 Systemic  illness  like  diabetes mellitus, hypertension,  collagen  
disorders  and  neurodegenerative  diseases   
 H/o drug  intake - ototoxic  drugs, anticonvulsant drugs,  
antimalignant drugs.   
 H/o head  injury 
 H/o prior  ear  surgery  were  excluded  from  the  study. 
CASE  SELECTION: 
Patients  who  came  with  the  symptoms  and  signs  suggestive  
of  hypothyroidism  such  as  easy  fatiguability,  dry  skin, hoarseness  of  
voice, cold  intolerance, weight  gain,  periorbital  swelling  and  
bradycardia  were  randomly  selected  from  the  medicine  outpatient  
department.  Thyroid  profile  was  done  for  all  of  them  which  include  
the  serum  parameters  of  TSH,  free T3,  free T4.  40  patients  diagnosed  
NEUROPERFECT 
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as  hypothyroidism   were  selected  as  study  subjects  and  40  age  
matched  healthy  females  with  normal  thyroid  profile  were  taken  as  
controls.    They   were  selected  from  the  general  population  in  
Coimbatore.  None  of  the  cases  and  controls  had  any  symptoms  and  
signs  of  CNS  dysfunction  and  none  of  them  showed  any  
abnormality  in  neurologic  examination  and  were  not  on  treatment  
with  thyroxine. 
MATERIALS  USED  FOR  THE  STUDY: 
 Proforma -  To obtain  detailed  history  and  to  record  the  
clinical  examination  findings. 
 Portable  weighing  machine – to  record   the  body   weight   in   
kilograms. 
 Stadiometer – to   measure   the   standing   height   in  
centimeters. 
 ERBA  thyro kit – To  measure  the  serum  levels  of  TSH,  
free T3  and free T4 . 
 Neuroperfect  EMG  2000  system  with  installed  BAER  
software  to  record  absolute  latencies  and  interpeak  
latencies. 
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METHODOLOGY : 
The  institutional  ethical  committee  approval  was  obtained  
prior  to  the  commencement  of  the  study  and  the  subjects  were  
selected  and  grouped.  The  study  was  carried  out  after  explaining  
the  procedure  in  detail  and  getting  informed  written  consent  from  
both  the  cases  and  controls.  BAER  recorded  between  10 A.M  to 2 
P.M.  All  the  techniques  of  measurement   were  maintained  uniformly  
throughout  the  study. 
The  study  protocol  involved, 
1. Detailed  history  was  elicited  from  them  to  diagnose  the  
hypothyroidism  and   to  rule  out  the  prior  neurological  and  
endocrine  disorders. 
2. Measurement  of  anthropometric  indices 
Weight  of  subject:  The   subjects   were   asked  to  stand   erect    
with  their  arms  relaxed    at  their  side,  with  both  feet  close  together.   
By   using  a  portable  standard  weighing   machine,  weight  in  
kilograms   was   recorded . 
COLLECTION OF BLOOD SAMPLE 
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Height  of  subject:  By   using   a   stadiometer ,  height  of  
subject  in   centimetres   was    measured  by   asking  the  subject    to  
stand   erect   and  the   vertical   height   was  measured. 
BMI  of  subject:  Body  Mass  Index    was  calculated   using   
the         Quetelet’s  index.      BMI =   Weight ( Kg) /  Height2 (m) 
3. A  thorough clinical  examination  of   the  study  subjects  were  
done.  It  consists  of  general  examination,  systemic  examination   
which  includes  respiratory  system,  cardiovascular  system,  
abdomen  and   central  nervous  system.  Otorhinolaryngological 
examination  was  done  for  the  presence  of   cerumen  in ear,  
abnormality  in  external  auditory  canal,  otorrhea,  and  foreign  
body  in  the  ear. 
4. All  participants  underwent  thyroid  profile measurement. 
Hormone  measurement: 
Thyroid  profile  includes  serum TSH,  free T4,  free T3  and   they  
measured  by  microplate  based  Enzyme  Linked  Immuno  Sorbent  
Assay (ELISA)    using  ERBA  kit.  This  method  is  based  on  one  step  
immune  enzymatic principle associated  with  the  Biotin – Streptavidin  
Technology.   
RINNE’S TEST 
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The  reference  values  are, 
 TSH – 0.4  to  5.5 µIU/ml 
 freeT3 – 1.4 to 4.2 pg/ml 
 freeT4 – 0.8 to 4.2 ng/ml  
5. Rinne’s  test  was  done  in  all  participants  to  compare  air  
conduction  with  the  bone  conduction  of  each  ear  separately.  
It  is  done  by  placing  the  base  of  the  vibrating  tuning  fork  of  
512Hz  over  the  mastoid  process  and  the  subject  is  asked  to  
raise  the  hand  when  she  stops  hearing  the  sound.  Then 
immediately  transfer  the   tuning  fork   which  is  still  vibrating 
to  the  side  of  the  head  and  is  held  in front  of  the  ear.   
If  the  hearing  is  normal,  the  subject  can  hear  even  after  he 
has  stopped  hearing the  vibrations  by  bone  conduction.  It  implies  
that  air  conduction  is  better  than  bone  conduction.  It  is  referred  as  
Rinne’s  positive.  If  there  is  CHL,  vibrations  are  not  heard  after  
bone  conduction  is  over.  It  is  referred  as  Rinne’s  negative.  
Weber’s  test  was  done  in  all  subjects  to  study  bone  
conduction.  The  base  of  the  vibrating  tuning  fork  of  512Hz   kept  
either   in  the  middle  of  the forehead or  on  the  vertex   and  the  
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subject was  asked  to indicate  in  which  ear  the  sound  is  heard  better  
or  heard  equally  in  both ears. This is  expressed  as  lateralization  of 
sound  to  a  particular  ear. 
Healthy  individuals  heard  the  vibrations  equally  in  both  the  
ears.         In  individuals  with  CHL,  the  sound  is  heard  better  by  the  
defective  ear.  In  individuals  with  SNHL,  the  sound  is  better  heard  
by  the  normal  ear. 
Procedure  for  recording  Brainstem  Auditory  Evoked  Potentials: 
The  BAER  was  recorded  by  using  Neuroperfect  EMG  2000 
system  with  installed  BAER  software.  The  subjects  were  asked  to  
sit  comfortably  in  fully  relaxed  state  and  with  eyes  closed.  The  
skin  at  the  site  of  placement  of  surface  electrode  was  cleaned  with  
spirit  and  the  electrodes  were  placed  on  the  scalp,  according  to   the  
10 - 20 International  System   using  EEG  paste. 
The  site  of  placement  of  electrodes: 
 Active  electrode  on  the  Verterx (Cz) 
 Reference  electrodes  over  the  Right  and  Left  mastoid  
process 
 Ground  electrode  on  the  forearm 
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All  the  above  sites  the  skin  to  electrode  contact  impedance  
was  kept  below  5 Kohms.  Each   ear  was  tested  separately.  The  
acoustic  stimuli  was  given  in  the  form  of  monaural  click  stimuli  by  
using  head  phones.  In  this  study  rarefaction  type  of  stimuli  is  used,  
because  it  will  produce  better  resolution  of  the  BAER  waves.  The  
filter  frequency  was  set  between  100 to 3000 Hz,  analysis  time  10ms  
and   sensitivity  1µV/division.  A  total  of  2000  stimuli  at  the  
frequency  of  10Hz   were  delivered  to  the  testing  ear  within   0.1ms.  
The   intensity  of  stimulus  was   60dB  above  the  sound  pressure  
level.   To  the  contralateral  ear  40dB  white  noise  was  given  for  
masking.  Two  or  three  trials  were  performed  in order  to  
demonstrate  the  consistency  of  the  wave  form.  The  absolute  
latencies  of  all  BAER  waves  and  their  IPL  of  I-III,  III-V and  I-V 
were  marked  with  the  help  of  digital  cursors  and  the  values  were  
noted  down. 
BAER RECORDING IN CONTROLS 
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BAER RECORDING IN CASES 
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STATISTICAL   ANALYSIS 
 
The  data  collected  from   the  selected  subjects  were  recorded   
in  a  Master  Chart.  The  mean  values  of  both  ears   were  calculated  
and  analyzed  with  the  help  of    Epidemiological  Information  
Package (EPI 2010)    which  developed  by   Centre for  Disease 
Control, Atlanta.  
 Using  this  software  mean,  standard  deviations   and   'p'  values 
were calculated.  Unpaired ‘t’ test was  used  to compare BAER  
latencies  and  interpeak  latencies  of  newly  diagnosed  hypothyroid  
patients  and  healthy  controls.  Pearson’s  correlation  coefficient  was  
calculated  using   Excel  software.  'p'  value  less than 0.05   was  
considered  to denote significant relationship.   
Microsoft  word  &  excel  were  used  to  create  the   tables,  
charts  and  graphs. 
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RESULTS 
The  present  study  was  carried  out  in  the  Research  laboratory,  
Department  of  Physiology, Coimbatore Medical College, Coimbatore. 
The  absolute  and  interpeak  latencies  of  BAER  were  recorded  by  
using  Neuroperfect  EMG  2000  system  with  installed  BAER  
software. 
1. Study population  
A  total  of  80  females  were included  in  the  study.  Among  
them     40 females  were  newly  diagnosed  hypothyroid  patients and  
40  females  were  normal  healthy  controls. They   divided  into  two  
groups:  
Group A – Newly  diagnosed Hypothyroid individuals 
Group B – Normal Healthy females 
The mean  age  was 37.05 years for  newly  diagnosed  hypothyroid  
females  and  36.02 years for normal  healthy females.   There  were  no  
significant  difference  between  the  groups  so  they   were  comparable.  
The mean  Body  Mass  Index   of  the  Group A   was  25.3 kg  and  
Group B was 23.1 kg.  The  hypothyroid  patients  had  higher  BMI  than  
control  group. 
 
 
88 
 
Table -1: Demographic characteristics of  Study  Population   
Variables Group  A Group  B   ‘p’ value 
Participants N=40 N=40  
Mean  age (years) 37.05 36.02 0.3028* 
Mean  Height(cm) 153.7 155.2 0.1825* 
Mean  Weight(kg) 59.7 55.7 0.0011** 
Mean  BMI 25.3 23.1 <0.0001** 
* - Non Significant, ** - Significant 
 
Figure -1: Height / Weight / BMI 
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Table 2 : Age Distribution 
Age Group 
(in years) 
Group A Group B 
No % No % 
20 – 30 9 22.5 13 32.5 
31 – 40  15 37.5 14 35.0 
41 – 50  16 40 13 32.5 
Total 40 100 40 100 
About  77.5%  of   the  newly  diagnosed  hypothyroid  females  were 
predominantly   in  the age  group  of  31 to 50 years                                        
Figure -2: Age  distribution   
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Table 3 : TSH (mIU/ml)/ T3 (pg/ml) / T4 (ng/ml) 
Thyroid 
profile 
Group A Group B 
‘P’ 
Mean SD Mean SD 
TSH(mIU/ml) 40.09 4.05 2.49 1.27 <0.0001  Significant 
T3 (pg/ml) 1.09 0.56 3.31 0.7 <0.0001 Significant 
T4 (ng/ml) 0.59 0.28 1.1 0.28 <0.0001 Significant 
There  was  significant  difference  in thyroid profile  between  study  and  
control  group. Hence  the  groups  were  comparable.  
Figure -3: Thyroid Profile  of  newly diagnosed hypothyroid patients  
                   and controls. 
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BAER  Recordings  
Among  the  Seven  Waveforms  of  BAER,   I, III, V  waves   are  
constant , clinically  useful  and  reproducible.  The   absolute  latencies  
I, III, V  and   IPL  I-III,  III-V, I-V  were  recorded  from  both  ears.  
The  mean  values  were  tabulated   in  table 4  and  5. 
Table 4 : Latencies in  newly diagnosed  in Hypothyroid patients  and  
controls 
Latencies 
Group A Group B 
‘p’ Value 
Mean S.D Mean S.D 
Right ear 
I 2.04 0.41 1.51 0.37 <0.0001  Significant 
III 4.85 0.75 3.78 0.72 <0.0001 Significant 
V 7.78 0.96 5.68 0.89 <0.0001 Significant 
Left  ear  
I 2.03 0.37 1.54 0.39 <0.0001  Significant 
III 4.86 0.81 3.74 0.73 <0.0001 Significant 
V 7.97 0.73 5.66 0.96 <0.0001 Significant 
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Table 5 :  Interpeak Latencies in  in  newly diagnosed  in  
Hypothyroid  patients  and  controls 
Interpeak 
Latencies 
Group A Group B  
 
‘p’ Value Mean SD Mean SD 
Right ear 
I – III  2.94 0.45 2.34 0.43 <0.0001  Significant 
III – V  2.57 0.39 2.06 0.4 <0.0001 Significant 
I – V   5.67 0.60 4.33 0.63 <0.0001 Significant 
Left  ear 
I – III  2.9 0.42 2.21 0.41 <0.0001  Significant 
III – V  2.63 0.34 1.97 0.41 <0.0001 Significant 
I - V  5.65 0.68 4.32 0.55 <0.0001 Significant 
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1.  Wave –I  latency 
 
The  mean Absolute latencies of  BAER  waveform in newly  diagnosed 
hypothyroid females were  2.04+0.41,  2.03+0.37  and   in healthy 
females were 1.51+0.37, 1.54+0.39  for  both  right  and  left ears 
respectively. The latencies were significantly prolonged (p <0.0001) in  
newly  diagnosed  hypothyroid  females  when compared  to  healthy  
females. The  comparison  of  wave  I  latencies  between  newly  
diagnosed hypothyroid females  and  healthy  females  is  shown  in  
figure 4. 
 Figure -4: Wave I latency 
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2. Wave III latency  
The  mean  absolute  latencies  in  newly  diagnosed hypothyroid females 
was  4.85+0.75  and  4.86+0.81  and  in   healthy  females  was  
3.78+0.72 and  3.74+0.73  for  both  right  and  left  ears  respectively.  A   
significant prolongation  was  seen  in  hypothyroid  individuals.  P  value  
for  both  ears  were  <0.0001. (figure 5) 
Figure -5: Wave III latency 
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3. Wave V latency  
The  mean  and  standard  deviation  of  wave  V  among  newly  
diagnosed hypothyroid females and  healthy  females  are  as  follows:   
Newly  diagnosed hypothyroid females  group  had  7.78+0.96  and  
7.97+0.73 for  right  and  left  ear  respectively. Healthy females  had  
5.68+0.89  and  5.66+0.96  while  recording  in  right  and  left  ear  
respectively. Newly  diagnosed hypothyroid females have  a significant  
increase  in  wave  V  latencies  when  compared  with  healthy  females 
(P value <0.0001 for both ears). 
Figure -6: Wave V latency  
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4. Interpeak  latency  I-III 
The  mean  Interpeak  latency I-III  in  newly  diagnosed hypothyroid 
females was 2.94+0.42  and  2.9+0.42  and  in  healthy  females  was  
2.28+0.43  and 2.21+0.41  for  right  and  left  ear  respectively.  
Comparing  the  mean  interpeak  latency  of  I-III   between  in  newly  
diagnosed  hypothyroid females  and  healthy  females  showed  a  
significant  prolongation  of  Interpeak  latency   among  newly  
diagnosed hypothyroid females (P value <0.0001 for both ears).   
Figure – 7 : Interpeak latency I – III  
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5. Inter peak latency III-V 
The overall mean Interpeak latencies of BAER waveform in newly  
diagnosed hypothyroid females  was  2.57+0.39 and 2.63+0.34  and  in 
control group was 2.06+0.40 and 1.97+0.41 for right and left ears 
respectively. There was  significant difference between  the  two  groups 
(P value<0.0001  for  both  right  and  left  ears).  The  results  are  
depicted  in  figure. 8. 
Figure – 8:  Interpeak Latency III - V    
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6. Inter peak  latency  I-V  
The  mean  and  standard  deviation  for  Interpeak  latencies  I-V  among  
newly  diagnosed hypothyroid females and  healthy  females  are  as  
follows.  The  I – V  Interpeak latency  of  Newly  diagnosed  
hypothyroid  females  have  of  5.67+0.60  and  5.65+0.68 for  right &  
left  ear  respectively. In  Healthy  females  the  I – V  Interpeak latency  
was    4.33+0.63  and 4.32+0.55 while  recording  in  right  and  left  ear  
respectively. The comparison between the two groups revealed 
significant ‘ p’ value of  <0.0001 in  both  ears. 
Figure 9: interpeak latency I- V  
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Table 6 : interaural  differences  of   Latencies   and  interpeak  
latencies  in  newly diagnosed  in Hypothyroid patients   
There  is  no  statistically  significant  interaural  differences  of   absolute  
latencies  and  interpeak  latencies  in  newly  diagnosed  hypothyroid  
patients.   
WAVES 
Right  Ear Left  Ear 
‘P’ 
Mean SD Mean SD 
I 2.04 0.41 2.03 0.37 = 0.9091  Not Significant 
III 4.85 0.75 4.86 0.81 
= 0.9545  
Not Significant 
V 7.78 0.96 7.97 0.73 
= 0.3221  
Not Significant 
I – III 2.94 0.42 2.9 0.42 
= 0.6713  
Not Significant 
III – V 2.57 0.39 2.63 0.34 
= 0.4655  
Not Significant 
I - V  5.67 0.60 5.65 0.68 = 0.8894  Not Significant 
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Table 7: Correlation between TSH, T3 & T4 and  latencies and 
interpeak Latencies 
There  was  positive  correlation  between  serum  TSH  and  the  BAER  
parameters  and  a  negative  correlation  was   found  with serum  free T3, 
free T4.   
 
Correlation with 
Correlation coefficient (r) of 
TSH T3 T4 
Right ear Latencies 
I 0.6085 -0.5265 -0.562 
III 0.5421 -0.3841 -0.4496 
V 0.3826 -0.3145 -0.299 
Left ear Latencies 
I 0.5681 -0.3881 -0.4654 
III 0.4703 -0.2562 -0.304 
V 0.2474 -0.0919 -0.1615 
Right ear inter peak Latencies 
I – III 0.3186 -0.2506 -0.2383 
III – V 0.1148 -0.0367 -0.0306 
I - V  0.2441 -0.1579 -0.2662 
Left ear interPeak Latencies 
I – III 0.3398 -0.1441 -0.2374 
III – V 0.0726 -0.1237 -0.0237 
I - V  0.2666 -0.1226 -0.2705 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
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DISCUSSION 
Among  the  thyroid  disorders  Hypothyroidism  is  one  of  the  
most  common  thyroid  dysfunction.  Central   nervous  system   
dysfunctions  are  the  important  consequences  of  hypothyroidism.  It  is  
associated  with  motor  deficits,  hearing  impairment,  mental  
retardation,  depression  and  memory  deficit.  The  most  common  
otolaryngological  manifestation  of  hypothyroidism  is  hearing  
impairment.11  It  may  be  conductive,  sensorineural  or  mixed  type  of  
hearing  loss.  Parving  et  al23  in  1983  and   Isam  et  al  in  200124   
were  reported  in  their  study  that  SNHL  was  the  predominant  type  
of   hearing  loss  in  hypothyroid  people.  Early  treatment  of  
hypothyroidism  with  thyroid  hormone  will  completely  revert  the  
hearing  impairment. 12 
Intact  anatomical  pathway,   relay  stations  and   proper  
myelination  of  nerves  are  some  of  the  factors  that  determine  the  
functional  ability   of  the  auditory  pathway. 16  The  absolute  and  inter 
peak  latencies  in  BAER  recordings  denote  the  conduction  of  nerve  
impulses  along  the  different  segments  of  the  auditory  pathway  and    
it  also can  be  used  as  a  tool  to  assess  the  hearing  impairment. 
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The  present  study  deals  with  the  BAER  changes  in  newly  
diagnosed  hypothyroid individuals.  The  Absolute  and  interpeak  
latencies  were  recorded  and  analyzed  between  newly  diagnosed  
hypothyroid  individuals  and  healthy  controls.  In   this   study  all   
participants  were  females. There are many studies which documented  
the  gender  differences  on  BAER  recordings.70,84,85 So in the  present  
study  only  the  hypothyroid  females  were  selected  to  get  more  
definite  results.  They were subjected to the  same  procedures,  technical  
and  environmental  conditions.    
Various  electrophysiological  studies  provide  an  almost  
unanimous  opinion  that  thyroid  hormone  substitution  promotes  
complete  reversal  of  hearing  loss. 11,13,15-17  Therefore  to  make  sure  
that  the  changes  in  the  BAER  parameters  are  exclusively  due  to  
thyroid  hormone  deficiency,  only  the  newly  diagnosed  hypothyroid  
females  were  selected  in  this  study.  
In  the  present  study  40  newly   diagnosed  hypothyroid  females  
of  mean  age  37.05 years  and  normal  healthy  females  of  mean  age  
36.02 years  were  included.  About  77.5%  of  the  newly  diagnosed  
hypothyroid  females  were  predominantly  in  the  age  group  of  31 to 
50 years.  It  is  consistent  with  the  report  of  myxedema  committee  in  
London  which  said   that  middle  aged  women  were  mostly  affected  
by  hypothyroidism  than  men. 45     
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The  BAER  are  far  field  subcortical  electrical  potentials  which  
helps  to  assess   the  auditory  sensory  process  from   distal  part  of  the  
cochlear  nerve  to  the  brainstem. 56,60  So  in  this  study   the  BAER  
was  recorded  among  newly  diagnosed  Hypothyroid  females  and   
healthy  females  and   found  that  there  was  statistically  significant  
(p<0.0001)   increase  in  absolute  latencies  of  wave  I, III  and  V  in  
newly  diagnosed  hypothyroid  females.  Similarly  interpeak  latencies I 
- III, III-V and  I-V  were  also  prolonged  significantly (p < 0.0001) in  
them  compared  to  controls .  This  was  consistent  with  the    study  
results  of  other  researchers. 11,72,78,79.   
A  study  done  to  investigate  the  neurophysiological  effects  of  
thyroid  hormone   by  Huang  et  al  observed   that  of  BAER  seen  in    
hypothyroid  patients  and  concluded  that  central  nervous  system  is  
more  sensitive  to  thyroid  hormone  deficiency. 79   
In  1981  Himelfarb  et  al  in  their  study  on  Auditory  brainstem  
responses  in  thyroid  disorders  inferred  that  the  changes  in  the  
BAER  pattern  was  characterized  by  prolonged  brainstem  conduction  
time,  flattened  peaks  and  diminished  amplitude. 80   
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CL Lai  from  Taiwan  analyzed  the  brainstem  auditory  evoked  
responses  from  20  patients  of  primary  hypothyroidism ,  observed  
that  the  peak  and  interpeak  latencies  were  delayed  significantly  in  
them. 87 
Anjana  et  al   in  their  evoked  potential  study  found  a  delayed  
conduction  of  impulses  along  the  superior  olivary  nucleus  which  
leads  an  increased  wave III  latency  but  did not   find  any  significant  
difference  in  other  absolute  and  IPL  of  hypothyroid  individuals.  
They  found  significant  improvement  in  wave  III  conduction  time  
and  IPL  of   I -III  after  thyroid  hormone  therapy.   By  this  study  
they  proposed  that  optimal  thyroid  hormone  level  is  required  to  
improve  the  excitability  of  neuronal  generators  in  the  brainstem  
auditory  pathway  particularly  for  wave  III  and  V. 16 
Another  study  done  by  Santos  et  al  to  find  the  audiological  
parameters  in  the patients  of  acute  hypothyroidism  concluded  that  
cochleovestibular  symptoms  like  hearing  loss  and  vertigo  were  more  
frequent  in  them.  In  addition  to  it  there  were  altered  BAER  values  
with  higher  latencies  of  waves  I , III  and  V  especially  absolute  
latency  of  wave  V  showed  statistically  significant  prolongation (P 
<0.05)  and  considered  that  this  delay  was  attributed  to  the  lesion  at  
the  level  of  endocochlear, retrocochlear and central structures of  the  
auditory  pathway.11  
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Khedr  et  al  did  a  study  in  hypothyroid  patients  and  found   a  
significant  prolongation  of  all  wave  latencies  and  inter peak  intervals 
of  BAER.  By  their  study  they  suggests  that   hypothyroidism  affects  
the  nervous  system  in  a  diffuse   manner.  All   these  findings  go  in 
favor  of  the  present  study  results. 9 
The  BAER  waveform  I  arises  from  the  peripheral  part  of  the  
cochlear  nerve.  The  wave  III  originates  from  superior  olivary  
nucleus  in  pons  whereas  wave V  arises  from inferior  colliculus  of  
midbrain.56,60  In  our  study  there  was  a  significant  increase  in  the   
absolute  latencies  of  wave  forms  I, III, V  was  observed.  Similar  to  
the  present  study   results, Thornton  and  Jarvis  from  MRC  institute  
of  hearing  research,  UK, 73 Santos et al,11  Khedr  et  al 9  and   Hohman  
et  al74  were  also  showed  increase  in  the  wave  latencies.  They  
suggested  that  this  may  be  due  to  slow  conduction  of  nerve  
impulses  along  the  auditory  pathway.  Because  the  BAER  wave  
latencies  depends   on   the  functional   integrity   and   myelination  of  
the  auditory  pathway. 16    
Hypothyroidism  being  a  metabolic  disorder   it  affects   the   
oxidative   activity   of   mitochondria,   lipid  level  in  the  CNS,   
protein   synthesis   and   degradation  which  leads  to  demyelination .11  
The  increased  absolute  latency of   I, III  and  V  in  this  study   
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indicates  that  the  thyroid  hormone  deficiency  affects  the  myelination  
of  both  peripheral  and  central   part  of  the  auditory  pathway.  It  was  
further  supported  by  the  molecular  level  experimental  studies. 
Moore  et  al   and   Knipper  et  al    inferred  that  thyroid  
hormone  is  essential  for  the  expression  of  myelin  genes  like  
peripheral  protein  zero(P0), major  basic  protein(MBP)  and  proteo  
lipoid  protein(PLP)  in  cochlea,  brainstem  and  auditory  cortex.  So  
thyroid   hormone   deficiency  will  lead  to  hypomyelination   of  the  
peripheral  and  central  part  of  the  intradural  segment  of  the  auditory  
nerve  and   produces  enhanced  wave  latencies. 41, 54, 88    
In  1983  Abbott  et  al  said  that  the  prolonged  central  
conduction  time  of  nerve  impulse  in  hypothyroidism  may  be  
attributed  to  low  body  temperature  and  altered  cerebral  
metabolism.55    
Regarding  Inter peak  latencies  of  BAER, the  IPL I-III  measures  
the neuronal conduction  along  the  VIII  nerve  across  the  subarachnoid  
space  into  lower  pons,   whereas  III - V  denotes  the   conduction  time  
from  lower  pons  to  midbrain .  The  IPL  I-V  measures  of  neuronal  
conduction time from the VIII nerve through pons  and midbrain. Thus 
the inter peak  latencies gives information  about  the  functional  integrity  
of  the  mid  portion  of  the  brainstem  auditory  pathway.56, 60, 63  
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In  the  present  study  there  was  a  significant  prolongation  of        
all  IPL  observed   in  newly  diagnosed  hypothyroid  patients.  This  
result  was  consistent  with  the  results  of  Anand  et  al72,   Di  Lorenzo  
et  al78,  Santos  et  al11 and  Khedr  et  al9.   
A  prospective  cohort  study  done   by  Chandrasekhar  et  al17  
and  another  cross  sectional  study  done  by  Gowri  V 89 discovered  a  
significant  delay  in  latencies  of  the  wave  forms  III ,  V  and  IPL  I-
V  in  acquired  hypothyroid  patients  without  treatment.  They  
explained  that  the  significant  prolongation  may  be   attributed  to  
hypothermia,  altered  metabolism  of  brain  and   dysfunctional   
regulatory  proteins  like  otoferlin,  prestin  which  are  necessary  for  
the   auditory  sensation .   
 Many  experimental  studies  have  been  done   at  molecular  level 
to  elucidate  the  relationship  between  thyroid  hormone  and  the  
auditory  function.  One  such  experimental  study  done  on  26  adult  
myxedematous  albino  rats  showed  the  reversible  dynamic  changes  in  
the  amplitude  of  wave III  of  BAER  and   concluded  that  the  lesion  
was  mainly  in  the  superior  olivary  nucleus  in  the  brainstem. 82   
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Saito  et  al,  in  their  study  on  hypothyroid  dogs,  found  
structural  changes  in  the  membranous  labyrinth  and  in  the  petrous  
part  of  the  temporal  bone  and also   demonstrated  the   neuronal  cell  
reduction  in  the  cerebral  cortex. 90 
Knipper  et  al  done   an  experimental  study   on   wister  rats,   
recorded  Auditory  brainstem  response  and  Distortion  product  
otoacoustic  emission(DPOAE) in  methimazole (MMI)  treated  adult  
rats  and  found  that    DPOAE  was  absent  and    Auditory  brainstem  
response  latencies  were prolonged  when  compared  with   controls.  
They  found  that  the  prolongation  of  auditory  brainstem  responses  as  
a  result  of  thyroxine  deficiency  before  the  onset  of  hearing  are  
permanent  and also  added  that  thyroxine  is  essential  for  the  
neuronal  and  structural  development  of  the  inner  ear,  as  well  as  for  
the  auditory  function.  So  its  deficiency  affects  the  auditory  system  
from  the  periphery  to  central  aspect  of  the  auditory  pathway  in  a  
centripetal  fashion.  The  BAER  provide  the  information  about  the   
maturation  of  central  auditory  process  which  includes  
myelinogenesis,   maturation  of  synapses  and  dendrites. 88 
Apart  from  the  above  electrophysiological,  experimental 
studies,  biochemical  and  basic  histological  studies  may  also  explain  
the  association  between  the  auditory  dysfunction  and  thyroid  
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hormone  deficiency.  By  using  immunohistochemistry  stains , 
researchers  found  the  presence  of  thyroid  receptors  in  the  spiral  
ganglion  and  inner  hair  cells  of  the  rat  cochlea.  Hypothyroidism  
which  affects  all  the  metabolic  functions  of  human  body  leads  to  
energy  deficit.  This  leads  to  reduced  oxidation  and   causes 
deposition  of  glycogen  along  the  nerves  which  results  in  axonal  
degeneration,  segmental  demyelination. This    constitutes  the  possible   
basic pathogenic mechanism of nervous dysfunction in hypothyroidism.91   
Bell  et  al  added  that  decreased  absorption  of  calcium  also  
contributes  to  the  delayed  synaptic  transmission  along  the  auditory  
pathway. 17   Deficiency  of  thyroid  hormone  down regulates  the  
voltage  gated  sodium  current  density  and  leads  to  reduced  firing  
frequency  and  delayed  action  potential  upstrokes  in turn  reduces  the  
conduction  velocity. 92 
The  overall  findings  signify  that  both  peripheral  and  central  
auditory  pathway   affected  by  hypothyroidism.  The  proposed  
possible  mechanisms  for  the  hearing  loss  in  hypothyroidism  are  
multifactorial,  like  defective  myelination, reduced  body  temperature,  
altered  cerebral  metabolism,  diminished  regulatory  protein  actions,  
reduced  sensitivity  of  sensory  receptors,  decreased  voltage  gated  
sodium current density and  axonal  degeneration  caused  by  deposition  
of  glycosaminoglycan. 
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In  contrary  to  the  above  studies,  some  of  the  researchers  
have  showed  disagreeing  results  in  their  studies.  A  study  by  
Vanasse   et  al  done  on  15  adult  hypothyroid  patients  of  age  
ranging  from  34  to  82  years  found   no  significant  differences  in  
BAER  before  treatment.   They  stressed  that  hearing  loss  in  these  
patients  may  be  due  to  aging  than  to  hypothyroidism. 93   
Several  studies  were  done  to  find  the  normative  data  of  
BAER  parameters  have  found  that  no  significant  difference  was   
exist  between  the  right  and  left  ears. 14  Similar  to  the  above  studies  
there  is  no  statistically  significant  inter aural  difference  found  in  this  
study (Table-6).  But  De  lorenzeo  et  al  measured  inter auricular  
difference  of  0.2ms of  wave  latencies. 78  
In  the  present  study  there  was  positive  correlation  of  BAER  
latencies  with  serum  TSH   and  negative  correlation  with  serum  free  
thyroid  hormone  levels.  This   was  consistent  with  the  following  
study  results.  Himelfarb  et  al  found  statistically  significant  relation  
between  the  hearing  loss  and  the  serum  level  of  low  free T4. 80   
Ben Tovim  et  al  done  an  experimental  study  on  rats,  inferred  
that  the  BAER  changes  are  directly  associated  with  the  serum  level  
of  free T4. This  correlation  suggests  that  there  is  direct   involvement  
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of  auditory  pathway  by  thyroid  hormone  deficiency  and  results  in  
delaying  of  impulse  transmission  time  in  BAER  recordings. 82  
 Many studies  have  shown  that  treatment  of  hypothyroidism  
with  thyroid  hormone   reverse  the  SNHL.  A  prospective  study  done  
in  goitrous  hypothyroidism  patients  found  both  subjective  and  
objective  improvement  in  hearing  after  thyroxine  treatment. 15  Karlos  
et  al11,  Yumnam  et  al16,  Thorton  et  al73  also showed  the  
improvement  in  the  BAER  latencies  after  thyroxine  supplementation.  
They  reasoned  out  that,  thyroid  hormone  enhances  the  synthesis  and  
release  of  neurotransmitters  and   also  increases  the  receptor  
sensitivity.  So  early  identification  of  the  involvement  of   nervous  
system  and  auditory  pathway   using  brainstem  auditory  evoked  
response  will  help   us  to  prevent  the  occurrence  of  sensori   neural  
hearing  loss  in  hypothyroid  patients.    
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SUMMARY 
 
 Brainstem  auditory  evoked  responses  were  recorded  in  newly  
diagnosed  hypothyroid  females  and  normal  healthy  females. 
 The  BAER  parameters  namely  absolute   and  inter peak  
latencies  were  analyzed  between    two  groups. 
 There  was  significant  prolongation  of  absolute  latencies  of  
waves  I,  III  and  V  observed  in  newly  diagnosed  hypothyroid  
females. 
 The  inter peak  latencies  I- III,  III - V  and  I -V were  also  
increased  significantly  in  newly  diagnosed  hypothyroid  females  
compared  to  normal  healthy  females. 
 There  was  direct  correlation  between  thyroid  profile  and  
BAER  latencies.   
 There  was  no  significant  difference  of  BAER  latencies   
between  right  and  left  ear  in  newly  diagnosed  hypothyroid  
females. 
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CONCLUSION 
 
Hearing    enables  us  to  collect,  process  and  interpret  sounds  
continuously  and  without  conscious  effort.  Once  sense  of  hearing  is  
fully  lost  there  is  no substitute.  None  of  the  other   senses  could  
replace  the  phenomenon  of hearing  sound;  that  is  why  hearing  is  
our  most  valuable  sense.  Life  is better  when  we  hear  better!  
When    hearing   is  lost,  it  will  lead   to   confusion,  
embarrassment,  anxiety,  depression,  frustration,  social  isolation  and  
diminished  work  capacity.  Though  impairment  of  hearing  at  an  
early stage  appears  negligible,  it  should  not  be  neglected.   
In  hypothyroidism  hearing  loss   is  the  most  common  
otolaryngological  manifestation . Hypothyroidism    is  a  multiorgan  
endocrine  disorder  which  affects  the  auditory  pathway  in  a diffuse  
pattern  and  causes   retro cochlear  sensori  neural  hearing  loss(SNHL).  
About  25%  of  adult  hypothyroid  patients  have  significant  hearing  
loss.   This  is  because,  thyroid  hormone  deficiency  causes  delayed  
neuronal  impulse  transmission   along  the  auditory  pathway   as  it  
plays  a  vital  role  in  the  development,  maturation  and  myelination  
of  auditory pathway.  
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Unlike   other   causes  of  SNHL,  hypothyroidism  induced  
hearing  loss  will  be  completely  curable  with  thyroxine  substitution.  
So  early  diagnosis  of  auditory  pathway  involvement  in  
hypothyroidism   will  help  us  to  initiate  early  treatment.  With  
advancement  of  computer  signal  processing  the  early  diagnosis  can  
be  done  by  evoked  potential  studies.  Among  those  studies  BAER  is  
a  highly  sensitive,  specific,   noninvasive  and  reproducible  method  
for  detecting  the  early  alterations  in  the  brainstem  auditory  pathway.  
It  not  only  gives  the  information  about  the  auditory  pathway, but   
also  tells  about  the  central  nervous  system  involvement. 
In  the  present  study,  we  found  a  significant  prolongation  of  
absolute  latencies  and  inter peak  latencies  of  brainstem  auditory 
evoked responses  in   newly  diagnosed  hypothyroid  individuals  even  
before  the  hearing  loss  overt.  So  it  should  be  recommended  that  
BAER  may  be  added  to  the  list  of  screening  tools  for  a  more  
accurate  and  early  assessment  of  neurological  involvement  in  
hypothyroid  individuals  to  initiate   treatment   to  ameliorate  
symptoms  and  prevent complications.  Because  Better  hearing  gives   
better  life  promise. 
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FUTURE  STUDY  PLAN: 
The  current  study  is  of  public  health  importance  as  it  suggests  that  
the  recording  of  BAER  in  newly  diagnosed  hypothyroid  patients  
and  thereby  advice   patients  regarding  early  treatment  and  
prevention  of  complications. 
 This  study  can  be  further  extended  in  these  patients  after    
attaining   euthyroid  state  to  find  out  the  reversibility  of  
SNHL. 
 This  study  can  be  done  among  children  suffering  from  
hypothyroidism  to  determine  the  role  of  thyroxine  on  the  
development  of  hearing. 
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CONSENT FORM 
 
Dr. V. Roseline Jesintha,  Post graduate  student  in  the  Department of 
Physiology,  Coimbatore  Medical  College  is  studying  the  
“BRAINSTEM  AUDITORY  EVOKED  RESPONSES  IN NEWLY 
DIAGNOSED  HYPOTHYROID  INDIVIDUALS”.    The  procedure  of  
estimation  of  free T3,  free T4  and  TSH  and  recording  of  Brainstem   
Auditory  Evoked Responses  were  explained   to  me  clearly.   
I  hereby  give  my  consent  to  participate  in  this  study.  The  data 
obtained  herein  may  be  used  for  research  and   publication. 
 
Name     :  
Place       :  
Signature : 
 
 
 
 
PROFORMA 
 
Name:                                                                 
Age: 
Sex:      
Occupation:                                                          
Address:                                                                         Ph. No: 
Present illness: 
H/o hoarseness of voice 
H/o cold intolerance 
H/o cramps 
H/o numbness 
H/o constipation/diarrhea 
H/o loss of hair  
H/o tinnitus 
H/o hard of hearing 
H/o vertigo 
H/o fever 
Menstrual H/o: 
H/o menorrhagia   
Duration :                                No. of pads / day: 
H/o passing of clots 
H/o  associated abdominal pain 
Past H/O: 
H/o drug intake 
H/o thyroid surgery 
H/o previous hospital admission 
H/o radiation exposure 
 
Family H/O: 
H/o thyroid disorder 
H/o hearing disorder 
Chronic illness: SHT, DM, IHD, TB, BA, EPILEPSY 
 
GENERAL EXAMINATION 
 
Built:       
Height: 
Weight:      BMI: 
VITALS: 
PR:       RR: 
 
BP:       Temp: 
 
SYSTEM EXAMINATION:                 
CVS:  
RS: 
Abdomen:  
CENTRAL NERVOUS SYSTEM 
 
1. Examination of the Motor System 
2. Examination of the Sensory System 
3. Examination of Reflexes  
INVESTIGATIONS 
Thyroid profile: 
Serum fT3 
Serum f T4 
TSH 
Otoscopy  Features:  
External  Auditory  Canal 
Tympanic  Membrane 
Hearing  Tests: 
Rinne’s Test 
Weber’s Test 
Brainstem  Auditory  Evoked  Response: 
Waves  Right  Ear Left  Ear 
Absolute  Latencies 
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V   
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I – III   
III - V   
I - V   
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